Elf-1	B-protein
and	O
Stat5	B-protein
bind	O
to	O
a	O
critical	O
element	O
in	O
a	O
new	O
enhancer	O
of	O
the	O
human	B-DNA
interleukin-2	I-DNA
receptor	I-DNA
alpha	I-DNA
gene	I-DNA
[	O
published	O
erratum	O
appears	O
in	O
Mol	O
Cell	O
Biol	O
1997	O
Apr	O
;	O
17	O
(	O
4	O
)	O
:	O
2351	O
]	O

The	O
interleukin	B-DNA
2	I-DNA
receptor	I-DNA
alpha-chain	I-DNA
(	I-DNA
IL-2R	I-DNA
alpha	I-DNA
)	I-DNA
gene	I-DNA
is	O
a	O
key	O
regulator	O
of	O
lymphocyte	O
proliferation	O
.	O

IL-2R	B-protein
alpha	I-protein
is	O
rapidly	O
and	O
potently	O
induced	O
in	O
T	B-cell_type
cells	I-cell_type
in	O
response	O
to	O
mitogenic	O
stimuli	O
.	O

Interleukin	B-protein
2	I-protein
(	O
IL-2	B-protein
)	O
stimulates	O
IL-2R	B-protein
alpha	I-protein
.	O

transcription	O
,	O
thereby	O
amplifying	O
expression	O
of	O
its	O
own	O
high-affinity	B-protein
receptor	I-protein
.	O

IL-2R	B-protein
alpha	I-protein
transcription	O
is	O
at	O
least	O
in	O
part	O
controlled	O
by	O
two	O
positive	B-protein
regulatory	I-protein
regions	I-protein
,	O
PRRI	B-DNA
and	O
PRRII	B-DNA
.	O

PRRI	B-DNA
is	O
an	O
inducible	B-DNA
proximal	I-DNA
enhancer	I-DNA
,	O
located	O
between	B-DNA
nucleotides	I-DNA
-276	I-DNA
and	I-DNA
-244	I-DNA
,	O
which	O
contains	O
NF-kappaB	B-DNA
and	I-DNA
SRE/CArG	I-DNA
motifs	I-DNA
.	O

PRRII	B-DNA
is	O
a	O
T-cell-specific	B-DNA
enhancer	I-DNA
,	O
located	O
between	O
nucleotides	O
-137	O
and	O
-64	O
,	O
which	O
binds	O
the	O
T-cell-specific	B-protein
Ets	I-protein
protein	I-protein
Elf-1	B-protein
and	O
HMG-I	B-protein
(	I-protein
Y	I-protein
)	I-protein
proteins	I-protein
.	O

However	O
,	O
none	O
of	O
these	O
proximal	O
regions	O
account	O
for	O
the	O
induction	O
of	O
IL-2R	O
alpha	O
transcription	O
by	O
IL-2	B-protein
.	O

To	O
find	O
new	O
regulatory	B-DNA
regions	I-DNA
of	O
the	O
IL-2R	B-DNA
alpha	I-DNA
gene	I-DNA
,	O
8.5	O
kb	O
of	O
the	O
5	O
'	O
end	O
noncoding	O
sequence	O
of	O
the	O
IL-2R	B-DNA
alpha	I-DNA
gene	I-DNA
have	O
been	O
sequenced	O
.	O

We	O
identified	O
an	O
86-nucleotide	O
fragment	O
that	O
is	O
90	O
%	O
identical	O
to	O
the	O
recently	O
characterized	O
murine	B-DNA
IL-2-responsive	I-DNA
element	I-DNA
(	O
mIL-2rE	B-DNA
)	O
.	O

This	O
putative	O
human	B-DNA
IL-2rE	I-DNA
,	O
designated	O
PRRIII	B-DNA
,	O
confers	O
IL-2	B-protein
responsiveness	O
on	O
a	O
heterologous	B-DNA
promoter	I-DNA
.	O

PRRIII	B-DNA
contains	O
a	O
Stat	B-DNA
protein	I-DNA
binding	I-DNA
site	I-DNA
that	O
overlaps	O
with	O
an	O
EBS	B-DNA
motif	I-DNA
(	O
GASd/EBSd	B-DNA
)	O
.	O

These	O
are	O
essential	O
for	O
IL-2	B-protein
inducibility	O
of	O
PRRIII/CAT	B-DNA
reporter	I-DNA
constructs	I-DNA
.	O

IL-2	B-protein
induced	O
the	O
binding	O
of	O
Stat5a	B-protein
and	I-protein
b	I-protein
proteins	I-protein
to	O
the	O
human	B-DNA
GASd	I-DNA
element	I-DNA
.	O

To	O
confirm	O
the	O
physiological	O
relevance	O
of	O
these	O
findings	O
,	O
we	O
carried	O
out	O
in	O
vivo	O
footprinting	O
experiments	O
which	O
showed	O
that	O
stimulation	O
of	O
IL-2R	B-protein
alpha	I-protein
expression	O
correlated	O
with	O
occupancy	O
of	O
the	O
GASd	B-DNA
element	I-DNA
.	O

Our	O
data	O
demonstrate	O
a	O
major	O
role	O
of	O
the	O
GASd/EBSd	B-DNA
element	I-DNA
in	O
IL-2R	B-protein
alpha	I-protein
regulation	O
and	O
suggest	O
that	O
the	O
T-cell-specific	B-protein
Elf-1	I-protein
factor	I-protein
can	O
serve	O
as	O
a	O
transcriptional	B-protein
repressor	I-protein
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Dec.	NULL
1996	NULL
,	NULL
p.	NULL
6829-6840	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Elf-1	NULL
and	NULL
StatS5	NULL
Bind	NULL
to	NULL
a	NULL
Critical	NULL
Element	NULL
in	NULL
a	NULL
New	NULL
Enhancer	NULL
of	NULL
the	NULL
Human	NULL
Interleukin-2	NULL
Receptor	NULL
«	NULL
Gene	NULL
PATRICK	NULL
LECINE	NULL
,	NULL
*	NULL
MICHELE	NULL
ALGARTE	NULL
,	NULL
'¢	NULL
PASCAL	NULL
RAMEIL	NULL
,	NULL
'	NULL
CAROL	NULL
BEADLING	NULL
,	NULL
``	NULL
%	NULL
PHILIPP	NULL
BUCHER	NULL
,	NULL
``	NULL
MARKUS	NULL
NABHOLZ	NULL
,	NULL
°	NULL
anp	NULL
JEAN	NULL
IMBERT'*	NULL
INSERM	NULL
U119	NULL
,	NULL
13009	NULL
Marseille	NULL
,	NULL
France	NULL
'	NULL
;	NULL
Lymphocyte	NULL
Activation	NULL
Laboratory	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
London	NULL
WC2A	NULL
3PX	NULL
,	NULL
United	NULL
Kingdom	NULL
``	NULL
;	NULL
and	NULL
Swiss	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
CH-1066	NULL
Epalinges	NULL
,	NULL
Switzerland	NULL
``	NULL
Received	NULL
5	NULL
June	NULL
1996/Returned	NULL
for	NULL
modification	NULL
9	NULL
July	NULL
1996/Accepted	NULL
23	NULL
September	NULL
1996	NULL
The	NULL
interleukin	NULL
2	NULL
receptor	NULL
«	NULL
-chain	NULL
(	NULL
IL-2Ra	NULL
«	NULL
)	NULL
gene	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

IL-2Ra	NULL
is	NULL
rapidly	NULL
and	NULL
potently	NULL
induced	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
stimuli	NULL
.	NULL

Interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
stimulates	NULL
IL-2Ra	NULL
transcription	NULL
,	NULL
thereby	NULL
amplifying	NULL
expression	NULL
of	NULL
its	NULL
own	NULL
high-affinity	NULL
receptor	NULL
.	NULL

IL-2Ra	NULL
«	NULL
transcription	NULL
is	NULL
at	NULL
least	NULL
in	NULL
part	NULL
controlled	NULL
by	NULL
two	NULL
positive	NULL
regulatory	NULL
regions	NULL
,	NULL
PRRI	NULL
and	NULL
PRRII	NULL
PRRI	NULL
is	NULL
an	NULL
inducible	NULL
proximal	NULL
enhancer	NULL
,	NULL
located	NULL
between	NULL
nucleotides	NULL
-276	NULL
and	NULL
-244	NULL
,	NULL
which	NULL
contains	NULL
NF-KB	NULL
and	NULL
SRE/CArG	NULL
motifs	NULL
.	NULL

PRRII	NULL
is	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
,	NULL
located	NULL
between	NULL
nucleotides	NULL
-137	NULL
and	NULL
-64	NULL
,	NULL
which	NULL
binds	NULL
the	NULL
T-cell-specific	NULL
Ets	NULL
protein	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
proteins	NULL
.	NULL

However	NULL
,	NULL
none	NULL
of	NULL
these	NULL
proximal	NULL
regions	NULL
account	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-2Ra	NULL
«	NULL
transcription	NULL
by	NULL
IL-2	NULL
.	NULL

To	NULL
find	NULL
new	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
,	NULL
8.5	NULL
kb	NULL
of	NULL
the	NULL
5	NULL
'	NULL
end	NULL
noncoding	NULL
sequence	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
have	NULL
been	NULL
sequenced	NULL
.	NULL

We	NULL
identified	NULL
an	NULL
86-nucleotide	NULL
fragment	NULL
that	NULL
is	NULL
90	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
recently	NULL
characterized	NULL
murine	NULL
IL-2-responsive	NULL
element	NULL
(	NULL
mIL-2rE	NULL
)	NULL
.	NULL

This	NULL
putative	NULL
human	NULL
IL-2rE	NULL
,	NULL
designated	NULL
PRRIII	NULL
,	NULL
confers	NULL
IL-2	NULL
responsiveness	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

PRRIII	NULL
contains	NULL
a	NULL
Stat	NULL
protein	NULL
binding	NULL
site	NULL
that	NULL
overlaps	NULL
with	NULL
an	NULL
EBS	NULL
motif	NULL
(	NULL
GASd/EBSd	NULL
)	NULL
.	NULL

These	NULL
are	NULL
essential	NULL
for	NULL
IL-2	NULL
inducibility	NULL
of	NULL
PRRIII/CAT	NULL
reporter	NULL
constructs	NULL
.	NULL

IL-2	NULL
induced	NULL
the	NULL
binding	NULL
of	NULL
StatSa	NULL
and	NULL
b	NULL
proteins	NULL
to	NULL
the	NULL
human	NULL
GASd	NULL
element	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
physiological	NULL
relevance	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
in	NULL
vivo	NULL
footprinting	NULL
experiments	NULL
which	NULL
showed	NULL
that	NULL
stimulation	NULL
of	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
correlated	NULL
with	NULL
occupancy	NULL
of	NULL
the	NULL
GASd	NULL
element	NULL
.	NULL

Our	NULL
data	NULL
demonstrate	NULL
a	NULL
major	NULL
role	NULL
of	NULL
the	NULL
GASd/EBSd	NULL
element	NULL
in	NULL
IL-2Ra	NULL
«	NULL
regulation	NULL
and	NULL
suggest	NULL
that	NULL
the	NULL
T-cell-specific	NULL
Elf-1	NULL
factor	NULL
can	NULL
serve	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

Interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
,	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
the	NULL
immune	NULL
re-sponse	NULL
,	NULL
is	NULL
secreted	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
upon	NULL
antigenic	NULL
stimulation	NULL
.	NULL

Binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
high-affinity	NULL
receptor	NULL
induces	NULL
proliferation	NULL
as	NULL
well	NULL
as	NULL
functional	NULL
differentiation	NULL
of	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
and	NULL
natural	NULL
killer	NULL
activation	NULL
(	NULL
63	NULL
,	NULL
68	NULL
,	NULL
69	NULL
,	NULL
74	NULL
)	NULL
.	NULL

The	NULL
high-affinity	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
consists	NULL
of	NULL
three	NULL
chains	NULL
:	NULL
IL-Z2Ra	NULL
,	NULL
IL-2R	NULL
$	NULL
B	NULL
,	NULL
,	NULL
and	NULL
IL-Z2Ry	NULL
,	NULL
,	NULL
(	NULL
7	NULL
,	NULL
35	NULL
,	NULL
67	NULL
,	NULL
71	NULL
)	NULL
.	NULL

The	NULL
two	NULL
latter	NULL
subunits	NULL
are	NULL
shared	NULL
by	NULL
other	NULL
cytokine	NULL
receptors	NULL
:	NULL
IL-2R	NULL
$	NULL
B	NULL
,	NULL
,	NULL
is	NULL
part	NULL
of	NULL
the	NULL
IL-15R	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
IL-2Ry	NULL
,	NULL
,	NULL
is	NULL
part	NULL
of	NULL
IL-4R	NULL
,	NULL
IL-7R	NULL
,	NULL
IL-9R	NULL
,	NULL
and	NULL
IL-15R	NULL
(	NULL
31	NULL
,	NULL
48	NULL
,	NULL
59	NULL
)	NULL
.	NULL

IL-2RB	NULL
,	NULL
,	NULL
and	NULL
IL-2Ry	NULL
,	NULL
are	NULL
present	NULL
constitutively	NULL
on	NULL
resting	NULL
T	NULL
lymphocytes	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
42	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
«	NULL
chain	NULL
of	NULL
IL-Z2R	NULL
appears	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
only	NULL
after	NULL
activation	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
34	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
human	NULL
IL-Z2R	NULL
«	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
two	NULL
positive	NULL
regulatory	NULL
regions	NULL
within	NULL
its	NULL
proximal	NULL
enhancer/promoter	NULL
region	NULL
,	NULL
located	NULL
between	NULL
nucleotides	NULL
-276	NULL
and	NULL
-244	NULL
and	NULL
between	NULL
nucleotides	NULL
-137	NULL
and	NULL
-64	NULL
,	NULL
designated	NULL
PRRI	NULL
and	NULL
PRRII	NULL
,	NULL
respectively	NULL
,	NULL
by	NULL
John	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
.	NULL

PRRI	NULL
contains	NULL
kB	NULL
and	NULL
SRE/CArG	NULL
box	NULL
regulatory	NULL
elements	NULL
and	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
IL-2Ra	NULL
expression	NULL
by	NULL
Tax	NULL
(	NULL
transcription	NULL
activator	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
)	NULL
as	NULL
well	NULL
as	NULL
by	NULL
stimulation	NULL
with	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
and	NULL
IL-1	NULL
.	NULL

Transient	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
INSERM	NULL
U119	NULL
,	NULL
27	NULL
Boulevard	NULL
Lei	NULL
Roure	NULL
,	NULL
13009	NULL
Marseille	NULL
,	NULL
France	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
33	NULL
)	NULL
4	NULL
91	NULL
75	NULL
84	NULL
04	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
33	NULL
)	NULL
4	NULL
91	NULL
26	NULL
03	NULL
64	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
imbert	NULL
@	NULL
infobiogen.fr	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Lady	NULL
Davis	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
The	NULL
Sir	NULL
Mortimer	NULL
B.	NULL
Davis-Jewish	NULL
General	NULL
Hospital	NULL
,	NULL
Montréal	NULL
,	NULL
Québec	NULL
H3T	NULL
1E2	NULL
,	NULL
Canada	NULL
.	NULL
}	NULL

Present	NULL
address	NULL
:	NULL
Division	NULL
of	NULL
Allergy-Immunology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
The	NULL
New	NULL
York	NULL
Hospital-Cornell	NULL
Medical	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
.	NULL

6829	NULL
transfection	NULL
experiments	NULL
have	NULL
suggested	NULL
that	NULL
NF-kB	NULL
and	NULL
an	NULL
SRE-related	NULL
protein	NULL
control	NULL
the	NULL
activity	NULL
of	NULL
PRRI	NULL
(	NULL
33	NULL
,	NULL
36	NULL
,	NULL
52	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
provided	NULL
strong	NULL
evidence	NULL
for	NULL
a	NULL
major	NULL
role	NULL
of	NULL
these	NULL
sites	NULL
by	NULL
in	NULL
vivo	NULL
genomic	NULL
footprinting	NULL
(	NULL
1	NULL
)	NULL
.	NULL

PRRII	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
an	NULL
Ets	NULL
family	NULL
protein	NULL
,	NULL
Elf-1	NULL
,	NULL
and	NULL
the	NULL
nonhis-tone	NULL
chromatin-associated	NULL
protein	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
basal	NULL
promoter	NULL
activity	NULL
and	NULL
T-cell	NULL
specificity	NULL
of	NULL
IL-2Ra	NULL
expression	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
receptor	NULL
induces	NULL
activation	NULL
of	NULL
cytoplasmic	NULL
tyrosine	NULL
kinases	NULL
belonging	NULL
to	NULL
the	NULL
Janus	NULL
kinase	NULL
(	NULL
Jak	NULL
)	NULL
family	NULL
(	NULL
58	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
Jak	NULL
family	NULL
consists	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
Jak3	NULL
,	NULL
and	NULL
Tyk2	NULL
(	NULL
13	NULL
,	NULL
21	NULL
,	NULL
32	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Cytokine	NULL
receptor	NULL
subunits	NULL
selectively	NULL
associate	NULL
with	NULL
one	NULL
Jak	NULL
kinase	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
24	NULL
and	NULL
60	NULL
)	NULL
.	NULL

The	NULL
IL-2Ry	NULL
,	NULL
,	NULL
chain	NULL
is	NULL
associated	NULL
with	NULL
Jak3	NULL
,	NULL
and	NULL
IL-2RB	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
Jak1	NULL
(	NULL
27	NULL
,	NULL
28	NULL
,	NULL
43	NULL
,	NULL
80	NULL
)	NULL
.	NULL

Downstream	NULL
effectors	NULL
of	NULL
the	NULL
Jak	NULL
kinases	NULL
are	NULL
the	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
proteins	NULL
)	NULL
.	NULL

This	NULL
family	NULL
of	NULL
proteins	NULL
at	NULL
present	NULL
includes	NULL
seven	NULL
mammalian	NULL
members	NULL
:	NULL
Statl	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
5a	NULL
,	NULL
5b	NULL
,	NULL
and	NULL
6	NULL
(	NULL
38	NULL
,	NULL
56	NULL
,	NULL
72	NULL
,	NULL
82	NULL
,	NULL
83	NULL
)	NULL
.	NULL

Stat5	NULL
proteins	NULL
are	NULL
activated	NULL
by	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-7	NULL
,	NULL
IL-9	NULL
(	NULL
29	NULL
)	NULL
,	NULL
IL-15	NULL
,	NULL
erythropoietin	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
prolactin	NULL
(	NULL
19	NULL
,	NULL
37	NULL
,	NULL
44	NULL
,	NULL
72	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
Jak	NULL
kinases	NULL
following	NULL
ligand-mediated	NULL
oligomerization	NULL
leads	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
.	NULL

Phosphorylated	NULL
Stat	NULL
proteins	NULL
dimerize	NULL
via	NULL
their	NULL
SH2	NULL
domains	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Dimers	NULL
can	NULL
enter	NULL
the	NULL
nucleus	NULL
and	NULL
bind	NULL
to	NULL
specific	NULL
DNA	NULL
sequences	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
22	NULL
,	NULL
24	NULL
,	NULL
and	NULL
60	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
Stat	NULL
complexes	NULL
including	NULL
StatS5	NULL
is	NULL
controlled	NULL
by	NULL
both	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
(	NULL
5	NULL
,	NULL
78	NULL
)	NULL
.	NULL

IL-2	NULL
stimulation	NULL
of	NULL
T	NULL
or	NULL
NK	NULL
cells	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat5	NULL
(	NULL
6	NULL
,	NULL
15	NULL
,	NULL
37	NULL
,	NULL
73	NULL
)	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
IL-2	NULL
stimulates	NULL
IL-Z2Ra	NULL
«	NULL
transcription	NULL
,	NULL
thereby	NULL
amplifying	NULL
expression	NULL
of	NULL
its	NULL
own	NULL
high	NULL
6830	NULL
LECINE	NULL
ET	NULL
AL	NULL
.	NULL

affinity	NULL
receptor	NULL
(	NULL
11	NULL
,	NULL
39	NULL
,	NULL
54	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
the	NULL
physiological	NULL
relevance	NULL
of	NULL
the	NULL
positive	NULL
regulation	NULL
of	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
transcription	NULL
by	NULL
IL-2	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
both	NULL
humans	NULL
(	NULL
53	NULL
)	NULL
and	NULL
mice	NULL
(	NULL
64	NULL
)	NULL
.	NULL

In	NULL
transgenic	NULL
mice	NULL
,	NULL
the	NULL
role	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
for	NULL
this	NULL
regulation	NULL
has	NULL
been	NULL
demonstrated	NULL
(	NULL
64	NULL
)	NULL
,	NULL
and	NULL
an	NULL
IL-2-responsive	NULL
enhancer	NULL
(	NULL
IL-2rE	NULL
)	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
murine	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
.	NULL

This	NULL
78-nucleotide	NULL
segment	NULL
maps	NULL
1.3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
site	NULL
and	NULL
contains	NULL
two	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
Stat	NULL
family	NULL
proteins	NULL
(	NULL
GAS	NULL
motif	NULL
)	NULL
and	NULL
a	NULL
potential	NULL
Ets-binding	NULL
site	NULL
(	NULL
EBS	NULL
)	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Using	NULL
nucleotide	NULL
sequence	NULL
analysis	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
an	NULL
876-nucleo-tide	NULL
segment	NULL
in	NULL
the	NULL
5°	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
that	NULL
is	NULL
66	NULL
%	NULL
identical	NULL
with	NULL
the	NULL
region	NULL
between	NULL
nucleotides	NULL
-900	NULL
and	NULL
-1700	NULL
in	NULL
the	NULL
murine	NULL
gene	NULL
.	NULL

It	NULL
includes	NULL
a	NULL
stretch	NULL
of	NULL
86	NULL
nucleotides	NULL
which	NULL
is	NULL
90	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
murine	NULL
IL-2rE	NULL
.	NULL

By	NULL
transient	NULL
transfection	NULL
experiments	NULL
we	NULL
show	NULL
that	NULL
this	NULL
putative	NULL
human	NULL
IL-2rE	NULL
,	NULL
here	NULL
designated	NULL
PRRIII	NULL
,	NULL
confers	NULL
IL-2	NULL
responsiveness	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

PRRIII	NULL
contains	NULL
two	NULL
Stat	NULL
binding	NULL
sites	NULL
,	NULL
one	NULL
GATA	NULL
site	NULL
,	NULL
and	NULL
two	NULL
EBS	NULL
motifs	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
factors	NULL
which	NULL
bind	NULL
to	NULL
IL-2rE	NULL
cis-acting	NULL
elements	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
and	NULL
DNA	NULL
affinity	NULL
purification	NULL
.	NULL

Point	NULL
mutations	NULL
and	NULL
in	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
revealed	NULL
a	NULL
major	NULL
role	NULL
of	NULL
the	NULL
distal	NULL
Stat-binding	NULL
site	NULL
which	NULL
overlaps	NULL
with	NULL
an	NULL
EBS	NULL
motif	NULL
.	NULL

PRRIII	NULL
and	NULL
its	NULL
mouse	NULL
homolog	NULL
are	NULL
the	NULL
first	NULL
clearly	NULL
identified	NULL
natural	NULL
IL-2	NULL
responsive	NULL
enhancers	NULL
,	NULL
and	NULL
the	NULL
functional	NULL
characterization	NULL
of	NULL
PRRIII	NULL
presented	NULL
here	NULL
contributes	NULL
to	NULL
the	NULL
elucidation	NULL
of	NULL
IL-2-stimulated	NULL
transcription	NULL
in	NULL
general	NULL
and	NULL
significantly	NULL
improves	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
.	NULL

It	NULL
thereby	NULL
opens	NULL
new	NULL
perspectives	NULL
for	NULL
the	NULL
comprehension	NULL
of	NULL
the	NULL
role	NULL
of	NULL
IL-Z2Ra	NULL
«	NULL
expression	NULL
in	NULL
immune	NULL
responses	NULL
.	NULL

(	NULL
This	NULL
paper	NULL
partially	NULL
fulfills	NULL
the	NULL
requirements	NULL
for	NULL
the	NULL
doctoral	NULL
degrees	NULL
of	NULL
P.	NULL
Lécine	NULL
and	NULL
P	NULL
.	NULL

Rameil	NULL
.	NULL
)	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
.	NULL

The	NULL
IL-2-dependent	NULL
human	NULL
T-cell	NULL
line	NULL
Kit225	NULL
(	NULL
18	NULL
)	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1650	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
containing	NULL
2	NULL
mM	NULL
1.-glutamine	NULL
and	NULL
1	NULL
nM	NULL
recombinant	NULL
IL-2	NULL
(	NULL
Eurocetus	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
arrested	NULL
in	NULL
a	NULL
quiescent	NULL
state	NULL
by	NULL
washing	NULL
them	NULL
twice	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
culturing	NULL
in	NULL
RPMI	NULL
1650	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
for	NULL
20	NULL
h	NULL
(	NULL
for	NULL
transient	NULL
transfection	NULL
experiments	NULL
)	NULL
or	NULL
for	NULL
48	NULL
h	NULL
(	NULL
for	NULL
EMSA	NULL
and	NULL
affinity	NULL
purification	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
)	NULL
.	NULL

Ba/F3	NULL
,	NULL
a	NULL
murine	NULL
proB	NULL
cell	NULL
line	NULL
,	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1650	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
containing	NULL
2	NULL
mM	NULL
1-glutamine	NULL
and	NULL
murine	NULL
IL-3	NULL
.	NULL

Murine	NULL
IL-3	NULL
was	NULL
obtained	NULL
as	NULL
a	NULL
supernatant	NULL
of	NULL
COS-1	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
murine	NULL
IL-3	NULL
cDNA	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
F.	NULL
Lee	NULL
,	NULL
DNAX	NULL
)	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
voluntary	NULL
,	NULL
healthy	NULL
blood	NULL
donors	NULL
and	NULL
maintained	NULL
for	NULL
3	NULL
days	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
phytohemagglutinin	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
in	NULL
RPMI	NULL
1650	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
containing	NULL
2	NULL
mM	NULL
L-glutamine	NULL
.	NULL

PBMC	NULL
were	NULL
arrested	NULL
in	NULL
a	NULL
quiescent	NULL
state	NULL
by	NULL
two	NULL
washes	NULL
in	NULL
PBS	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1650	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
for	NULL
20	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
50	NULL
U	NULL
of	NULL
recombinant	NULL
IL-2	NULL
per	NULL
ml	NULL
as	NULL
indicated	NULL
in	NULL
figure	NULL
legends	NULL
.	NULL

EMSAs	NULL
,	NULL
affinity	NULL
purification	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
,	NULL
and	NULL
Western	NULL
blots	NULL
(	NULL
immunoblots	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
lysis	NULL
of	NULL
4	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
ml	NULL
for	NULL
20	NULL
min	NULL
at	NULL
40°C	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
phenyl	NULL
methylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
chymostatin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
precleared	NULL
by	NULL
centrifugation	NULL
at	NULL
13,000	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Synthetic	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
.	NULL

The	NULL
following	NULL
probes	NULL
were	NULL
used	NULL
(	NULL
GAS	NULL
motifs	NULL
are	NULL
underlined	NULL
;	NULL
EBS	NULL
and	NULL
GATA	NULL
motifs	NULL
are	NULL
doubly	NULL
underlined	NULL
;	NULL
the	NULL
mutated	NULL
nucleotides	NULL
are	NULL
in	NULL
boldface	NULL
)	NULL
:	NULL
FeyRI-GAS	NULL
,	NULL
GTATITCCCAGAAAAG	NULL
GAAC	NULL
;	NULL
-	NULL
FeyRI-mGAS	NULL
,	NULL
GTATTGACCAGAAAAGGAAC	NULL
;	NULL
-	NULL
IL-2Ra-GASd/	NULL
EBSd	NULL
,	NULL
TTTCTTCTAGGAAGTACC	NULL
;	NULL
IL-2R	NULL
«	NULL
-m1GASd	NULL
,	NULL
TTTCTGATAGGAA	NULL
GTACC	NULL
;	NULL
TTTCGGCTAGGAAGTACC	NULL
;	NULL
IL-2R	NULL
«	NULL
-mEBSd	NULL
,	NULL
TTTCTTCTCCGAAGTACC	NULL
;	NULL
IL-2R	NULL
«	NULL
-GASp/GATA	NULL
,	NULL
ACATITCTGATAATAG	NULL
AATT	NULL
;	NULL
EBSa	NULL
,	NULL
GATAACAGGAAGTGGTTGTA	NULL
;	NULL
EBSz	NULL
,	NULL
GATAAACACCAAGT	NULL
GGTTGTA	NULL
.	NULL

To	NULL
reveal	NULL
GAS-binding	NULL
proteins	NULL
,	NULL
8	NULL
wl	NULL
of	NULL
whole-cell	NULL
extracts	NULL
,	NULL
equivalent	NULL
to	NULL
3	NULL
10°	NULL
cells	NULL
,	NULL
was	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1.2	NULL
ul	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
1	NULL
mg/ml	NULL
in	NULL
H	NULL
,	NULL
O	NULL
)	NULL
;	NULL
5	NULL
x	NULL
10*	NULL
cpm	NULL
of	NULL
labeled	NULL
probe	NULL
(	NULL
approxi-mately	NULL
1	NULL
ng	NULL
)	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
reaction	NULL
was	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

an	NULL
additional	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N	NULL
'	NULL
-2-ethanesulfonic	NULL
acid	NULL
)	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
[	NULL
ethylene	NULL
glycol-bis	NULL
(	NULL
B-aminoethyl	NULL
ether	NULL
)	NULL
-N-N-N'-N	NULL
'	NULL
-tetraacetic	NULL
acid	NULL
]	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
,	NULL
0.25	NULL
mg	NULL
of	NULL
tRNA	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
2	NULL
%	NULL
Ficoll	NULL
.	NULL

Complexes	NULL
were	NULL
separated	NULL
on	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
unlabeled	NULL
oligonucleotides	NULL
were	NULL
preincubated	NULL
with	NULL
cell	NULL
extracts	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

Supershift	NULL
assays	NULL
of	NULL
GAS-binding	NULL
proteins	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
the	NULL
extracts	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
either	NULL
anti-MGF/StatSa	NULL
(	NULL
17	NULL
)	NULL
or	NULL
anti-StatS	NULL
C-17	NULL
,	NULL
directed	NULL
against	NULL
amino	NULL
acids	NULL
711	NULL
to	NULL
727	NULL
of	NULL
murine	NULL
StatSb	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Anti-Stat5	NULL
C-17	NULL
recognizes	NULL
both	NULL
Stata	NULL
and	NULL
StatSb	NULL
proteins	NULL
including	NULL
their	NULL
alternatively	NULL
spliced	NULL
forms	NULL
or	NULL
anti-Stat3	NULL
(	NULL
UBI	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
*°P-labeled	NULL
probe	NULL
.	NULL

Supershift	NULL
experiments	NULL
of	NULL
EBS	NULL
binding	NULL
proteins	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
the	NULL
binding	NULL
reactions	NULL
with	NULL
either	NULL
anti-Elf-1	NULL
or	NULL
anti-Ets-1/Ets-2	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
or	NULL
with	NULL
anti-Ets1/2	NULL
#	NULL
8	NULL
,	NULL
anti-Fli-1	NULL
#	NULL
61	NULL
,	NULL
or	NULL
anti-Tel	NULL
#	NULL
69	NULL
(	NULL
2	NULL
,	NULL
55	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
*°P-labeled	NULL
probe	NULL
.	NULL

DNA	NULL
binding	NULL
proteins	NULL
were	NULL
isolated	NULL
from	NULL
whole-cell	NULL
extracts	NULL
from	NULL
2	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
,	NULL
precleared	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
insolubilized	NULL
protein	NULL
A	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
by	NULL
incubation	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
5'-biotinylated	NULL
oligonucleotides	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
as	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
,	NULL
nonbiotinylated	NULL
oligonucleotides	NULL
were	NULL
added	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
before	NULL
addition	NULL
of	NULL
biotinylated	NULL
oligonucleotides	NULL
.	NULL

Complexes	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
lysis	NULL
buffer	NULL
,	NULL
eluted	NULL
in	NULL
sample	NULL
buffer	NULL
,	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacryl-amide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
polyvinylene	NULL
difluo-ride	NULL
membranes	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
the	NULL
StatSa-	NULL
and	NULL
Stat5b-specific	NULL
antisera	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
and	NULL
the	NULL
anti-Elf-1	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Plasmids	NULL
and	NULL
mutagenesis	NULL
.	NULL

A	NULL
genomic	NULL
8.5-kb	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
5'-end	NULL
noncoding	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL-2Re	NULL
gene	NULL
was	NULL
subcloned	NULL
from	NULL
the	NULL
Charon	NULL
4A	NULL
phage	NULL
clone	NULL
A39	NULL
(	NULL
23	NULL
)	NULL
into	NULL
pUC18	NULL
.	NULL

The	NULL
complete	NULL
sequence	NULL
was	NULL
determined	NULL
by	NULL
shotgun	NULL
and	NULL
oligo-primed	NULL
gene	NULL
walking	NULL
and	NULL
will	NULL
be	NULL
published	NULL
elsewhere	NULL
(	NULL
332	NULL
)	NULL
.	NULL

The	NULL
different	NULL
fragments	NULL
of	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pTK4-CAT	NULL
.	NULL

This	NULL
vector	NULL
was	NULL
derived	NULL
(	NULL
41	NULL
)	NULL
by	NULL
inserting	NULL
the	NULL
multiple	NULL
cloning	NULL
site	NULL
of	NULL
pSP73	NULL
(	NULL
Promega	NULL
)	NULL
into	NULL
NdeI-	NULL
and	NULL
HindIIl-digested	NULL
pTK3-CAT	NULL
.	NULL

pTK4-CAT/963	NULL
(	NULL
5'-3	NULL
'	NULL
)	NULL
contains	NULL
the	NULL
Pvull/SphI	NULL
fragment	NULL
of	NULL
IL-2Ra	NULL
genomic	NULL
DNA	NULL
.	NULL

pTK4-CAT/250	NULL
(	NULL
5'-3	NULL
'	NULL
)	NULL
and	NULL
pTK4-CAT/250	NULL
(	NULL
3'-5	NULL
``	NULL
)	NULL
contain	NULL
the	NULL
250-nucleotide	NULL
Xbal	NULL
fragment	NULL
of	NULL
the	NULL
IL-2Ra	NULL
5°	NULL
flanking	NULL
region	NULL
in	NULL
alternative	NULL
orientations	NULL
.	NULL

pCMV-CAT	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
GRR3	NULL
was	NULL
obtained	NULL
from	NULL
D.	NULL
Cantrell	NULL
.	NULL

Expression	NULL
vectors	NULL
for	NULL
MGF/StatSa	NULL
(	NULL
pXM/StatSa	NULL
)	NULL
and	NULL
mStatSb	NULL
(	NULL
pXM/StatSb	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
F.	NULL
Gouilleux	NULL
(	NULL
38	NULL
,	NULL
72	NULL
)	NULL
,	NULL
for	NULL
Elf-1	NULL
from	NULL
J.	NULL
M.	NULL
Leiden	NULL
(	NULL
70	NULL
)	NULL
,	NULL
and	NULL
for	NULL
Ets-1	NULL
from	NULL
J.	NULL
Ghysdael	NULL
.	NULL

Mutagenesis	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Transformer	NULL
Site-Directed	NULL
Mutagenesis	NULL
Kit	NULL
(	NULL
Clontech	NULL
)	NULL
and	NULL
pUC19	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
oligonucleotide	NULL
primers	NULL
used	NULL
to	NULL
disrupt	NULL
the	NULL
GASd	NULL
and	NULL
EBSd	NULL
motifs	NULL
were	NULL
mGASd	NULL
(	NULL
CCGCTGTTCTGAGCAGTTTC	NULL
GGCTAGGAAGTACC	NULL
)	NULL
and	NULL
mEBSd	NULL
(	NULL
CTGTTCTGAGCAGTTTCTTCTCCG	NULL
AAGTACCAAAC	NULL
)	NULL
.	NULL

The	NULL
choice	NULL
for	NULL
the	NULL
underlined	NULL
nucleotide	NULL
substitutions	NULL
was	NULL
based	NULL
on	NULL
previous	NULL
studies	NULL
in	NULL
which	NULL
either	NULL
factor	NULL
binding	NULL
or	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
particular	NULL
binding	NULL
site	NULL
was	NULL
destroyed	NULL
(	NULL
5	NULL
,	NULL
77	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

IL-2-starved	NULL
Kit225	NULL
cells	NULL
(	NULL
1.5	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
electrotransfected	NULL
in	NULL
a	NULL
BioRad	NULL
Gene	NULL
Pulser	NULL
(	NULL
330	NULL
V	NULL
,	NULL
9505F	NULL
)	NULL
with	NULL
25	NULL
ug	NULL
of	NULL
IL-2Re	NULL
enhancer	NULL
constructs	NULL
or	NULL
10	NULL
pg	NULL
of	NULL
pCMV-CAT	NULL
and	NULL
GRR3-CAT	NULL
plasmids	NULL
.	NULL

Amounts	NULL
of	NULL
expression	NULL
vectors	NULL
used	NULL
in	NULL
transfections	NULL
are	NULL
indicated	NULL
in	NULL
figure	NULL
legends	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
half	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
maintained	NULL
for	NULL
12	NULL
to	NULL
16	NULL
h	NULL
in	NULL
RPMI	NULL
1650	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
and	NULL
half	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
nM	NULL
IL-2	NULL
.	NULL

Cell	NULL
lysis	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
CAT	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
with	NULL
50	NULL
ug	NULL
of	NULL
cell	NULL
extracts	NULL
.	NULL

In	NULL
vivo	NULL
footprint	NULL
analysis	NULL
.	NULL

Genomic	NULL
footprint	NULL
analyses	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
1	NULL
)	NULL
by	NULL
the	NULL
dimethyl	NULL
sulfate	NULL
(	NULL
DMS	NULL
)	NULL
/ligation-mediated	NULL
PCR	NULL
(	NULL
LM-PCR	NULL
)	NULL
method	NULL
with	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
methylated	NULL
genomic	NULL
DNA	NULL
purified	NULL
from	NULL
Kit225	NULL
and	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
following	NULL
oligonucleotide	NULL
primers	NULL
were	NULL
used	NULL
for	NULL
the	NULL
coding	NULL
strand	NULL
:	NULL
primer	NULL
1	NULL
,	NULL
GGAACAAGTTCAAGAAAGG	NULL
AAC	NULL
(	NULL
[	NULL
-4043	NULL
,	NULL
-4064	NULL
]	NULL
,	NULL
T	NULL
,	NULL
,	NULL
59°C	NULL
)	NULL
;	NULL
primer	NULL
2	NULL
,	NULL
TAACTAGGTCATCCAGGACA	NULL
GCCG	NULL
(	NULL
[	NULL
-4078	NULL
,	NULL
-4102	NULL
]	NULL
,	NULL
T	NULL
,	NULL
,	NULL
63°C	NULL
)	NULL
;	NULL
primer	NULL
3	NULL
,	NULL
CATCCAGGACAGCCGGTCA	NULL
ACAGTGCAAG	NULL
(	NULL
[	NULL
-4088	NULL
,	NULL
-4116	NULL
]	NULL
,	NULL
T	NULL
,	NULL
,	NULL
68°C	NULL
)	NULL
.	NULL

For	NULL
the	NULL
noncoding	NULL
strand	NULL
,	NULL
we	NULL
used	NULL
primer	NULL
4	NULL
,	NULL
TCACCCCACTGTACGTCTA	NULL
(	NULL
[	NULL
-4175	NULL
,	NULL
-4157	NULL
]	NULL
,	NULL
T	NULL
,	NULL
,	NULL
60°C	NULL
)	NULL
;	NULL
primer	NULL
5	NULL
,	NULL
AGTGGTCITAAACCTAAGGGAAGGC	NULL
(	NULL
[	NULL
-4249	NULL
,	NULL
-4225	NULL
]	NULL
,	NULL
T	NULL
,	NULL
,	NULL
63°C	NULL
)	NULL
;	NULL
and	NULL
primer	NULL
6	NULL
,	NULL
CCTAAGGGAAGGCAGTCTAGGTCAG	NULL
(	NULL
[	NULL
-4237	NULL
,	NULL
-4213	NULL
]	NULL
,	NULL
T	NULL
,	NULL
,	NULL
68°C	NULL
)	NULL
.	NULL

At	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
analyze	NULL
cach	NULL
strand	NULL
of	NULL
the	NULL
PPRIII	NULL
in	NULL
both	NULL
Kit225	NULL
and	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

RESULTS	NULL
A	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
IL-2rE	NULL
.	NULL

The	NULL
proximal	NULL
enhancer/promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2R	NULL
«	NULL
gene	NULL
characterized	NULL
to	NULL
date	NULL
does	NULL
not	NULL
fully	NULL
account	NULL
for	NULL
the	NULL
cell	NULL
type	NULL
specificity	NULL
and	NULL
the	NULL
activation-dependent	NULL
regulation	NULL
of	NULL
human	NULL
IL-Z2Ra	NULL
gene	NULL
transcription	NULL
(	NULL
8	NULL
,	NULL
26	NULL
,	NULL
and	NULL
our	NULL
unpublished	NULL
obser-	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
Jak-Stat	NULL
ACTIVATION	NULL
OF	NULL
IL-2Re	NULL
«	NULL
GENE	NULL
6831	NULL
A	NULL
Xbal	NULL
|	NULL
HindIII	NULL
11	NULL
Pyull	NULL
i-	NULL
Xbal	NULL
Kbal	NULL
EcoRI	NULL
i	NULL
-	NULL
Xbal	NULL
i	NULL
EcoRI	NULL
|	NULL
Pstl	NULL
Pstl	NULL
i	NULL
[	NULL
BamHI	NULL
EcoRI	NULL
i	NULL
||	NULL
Sphl	NULL
_	NULL
|_	NULL
Pst	NULL
Pst	NULL
i	NULL
Sphl	NULL
PoP	NULL
}	NULL
i	NULL
SSII	NULL
i0	NULL
i_-	NULL
Hind	NULL
{	NULL
fI	NULL
-	NULL
Psi	NULL
i	NULL
I	NULL
i	NULL
EcoRI	NULL
Human	NULL
-	NULL
L-	NULL
L_	NULL
J	NULL
L_	NULL
j	NULL
L_	NULL
_	NULL
[	NULL
-1242	NULL
,	NULL
+251	NULL
]	NULL
|	NULL
o	NULL
|	NULL
Byull/SphI	NULL
[	NULL
-4473	NULL
,	NULL
-3510	NULL
]	NULL
C	NULL
Xbal	NULL
[	NULL
-4260	NULL
,	NULL
-40101	NULL
Mouse	NULL
H	NULL
--	NULL
A	NULL
[	NULL
-1726	NULL
,	NULL
-894	NULL
]	NULL
[	NULL
-818	NULL
,	NULL
-602	NULL
]	NULL
1-370	NULL
,	NULL
1651	NULL
B	NULL
Human	NULL
:	NULL
GASsd/Epsd	NULL
GASp/GATA	NULL
EBSp	NULL
-4190	NULL
-4180	NULL
-4170	NULL
-4160	NULL
-4150	NULL
-4140	NULL
-4130	NULL
-4120	NULL
GCTGTTCTCAGCAGTTTCTTCTAGGAACTACCAAACATTTCTGATAATACAATTGACCAATTTCCTCATGCAACTGAGACTCAGCTT	NULL
oo	NULL
GATATGATCTGCAGTTTCTTCTGAGAACTACCACACAT	NULL
TTCTGATAACAGACTTGAGCAACTTCCTSAT	NULL
-	NULL
ATGTGAGACTCAGCT	NULL
'	NULL
P	NULL
-1380	NULL
-1370	NULL
-1360	NULL
-1350	NULL
-1340	NULL
-1330	NULL
-1320	NULL
-1310	NULL
-1300	NULL
Mouse	NULL
:	NULL
GASd	NULL
GASp/GATA	NULL
EBSp	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Restriction	NULL
map	NULL
of	NULL
the	NULL
genomic	NULL
8.5-kb	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
5	NULL
'	NULL
end	NULL
noncoding	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

The	NULL
portion	NULL
previously	NULL
reported	NULL
from	NULL
position	NULL
-1242	NULL
to	NULL
+251	NULL
(	NULL
8	NULL
)	NULL
is	NULL
represented	NULL
by	NULL
a	NULL
striped	NULL
arrow	NULL
.	NULL

Nucleotide	NULL
numbers	NULL
refer	NULL
to	NULL
the	NULL
major	NULL
site	NULL
of	NULL
transcription	NULL
initiation	NULL
(	NULL
+1	NULL
)	NULL
.	NULL

The	NULL
Pvull/SpAI	NULL
fragment	NULL
(	NULL
position	NULL
-4473	NULL
to	NULL
-3510	NULL
,	NULL
963	NULL
nucleotides	NULL
)	NULL
and	NULL
the	NULL
Xbel	NULL
fragment	NULL
(	NULL
position	NULL
-4260	NULL
to	NULL
-4010	NULL
,	NULL
250	NULL
nucleotides	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
two	NULL
open	NULL
boxes	NULL
.	NULL

The	NULL
regions	NULL
conserved	NULL
in	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
are	NULL
indicated	NULL
by	NULL
three	NULL
lines	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
panel	NULL
A	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Partial	NULL
sequence	NULL
comparison	NULL
of	NULL
the	NULL
distal	NULL
region	NULL
conserved	NULL
between	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
IL-2Ra	NULL
genes	NULL
.	NULL

The	NULL
mouse	NULL
sequence	NULL
corresponds	NULL
to	NULL
the	NULL
murine	NULL
IL-2rE	NULL
C3	NULL
fragment	NULL
(	NULL
65	NULL
)	NULL
.	NULL

The	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
known	NULL
transcription	NULL
factors	NULL
are	NULL
in	NULL
boldface	NULL
.	NULL

The	NULL
putative	NULL
GAS	NULL
elements	NULL
are	NULL
underlined	NULL
(	NULL
single	NULL
line	NULL
)	NULL
,	NULL
and	NULL
the	NULL
putative	NULL
EBS	NULL
and	NULL
GATA	NULL
elements	NULL
are	NULL
double	NULL
underlined	NULL
.	NULL

The	NULL
suffixes	NULL
d	NULL
and	NULL
p	NULL
indicate	NULL
distal	NULL
and	NULL
proximal	NULL
elements	NULL
within	NULL
the	NULL
conserved	NULL
core	NULL
region	NULL
.	NULL

vations	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
its	NULL
5	NULL
flanking	NULL
region	NULL
has	NULL
only	NULL
been	NULL
reported	NULL
up	NULL
to	NULL
nucleotide	NULL
position	NULL
-	NULL
1422	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
76	NULL
)	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
organization	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
«	NULL
chain	NULL
locus	NULL
,	NULL
the	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
was	NULL
determined	NULL
up	NULL
to	NULL
position	NULL
-9365	NULL
bp	NULL
(	NULL
EMBL	NULL
accession	NULL
number	NULL
,	NULL
Z70243	NULL
)	NULL
(	NULL
33a	NULL
)	NULL
.	NULL

Computer	NULL
searches	NULL
revealed	NULL
that	NULL
,	NULL
apart	NULL
from	NULL
the	NULL
already	NULL
reported	NULL
proximal	NULL
segment	NULL
(	NULL
66	NULL
)	NULL
,	NULL
two	NULL
other	NULL
conserved	NULL
regions	NULL
are	NULL
shared	NULL
by	NULL
human	NULL
and	NULL
murine	NULL
IL-2Ra	NULL
«	NULL
5'-flanking	NULL
regions	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
first	NULL
is	NULL
a	NULL
short	NULL
fragment	NULL
of	NULL
222	NULL
nucleotides	NULL
(	NULL
position	NULL
-2297	NULL
to	NULL
-2084	NULL
in	NULL
humans	NULL
and	NULL
-818	NULL
to	NULL
=-602	NULL
in	NULL
mice	NULL
)	NULL
with	NULL
60	NULL
%	NULL
identity	NULL
.	NULL

The	NULL
second	NULL
fragment	NULL
encompasses	NULL
876	NULL
nucleotides	NULL
(	NULL
position	NULL
-4522	NULL
to	NULL
-3676	NULL
in	NULL
humans	NULL
and	NULL
-1726	NULL
to	NULL
-894	NULL
in	NULL
mice	NULL
)	NULL
and	NULL
displays	NULL
66	NULL
%	NULL
identity	NULL
between	NULL
the	NULL
two	NULL
species	NULL
.	NULL

It	NULL
contains	NULL
a	NULL
core	NULL
sequence	NULL
of	NULL
86	NULL
nucleotides	NULL
that	NULL
shows	NULL
90	NULL
%	NULL
identity	NULL
and	NULL
corresponds	NULL
to	NULL
the	NULL
recently	NULL
identified	NULL
mouse	NULL
IL-	NULL
2-responsive	NULL
C3	NULL
region	NULL
(	NULL
65	NULL
)	NULL
.	NULL

The	NULL
alignment	NULL
between	NULL
this	NULL
portion	NULL
(	NULL
position	NULL
-4199	NULL
to	NULL
-4114	NULL
)	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
and	NULL
the	NULL
mouse	NULL
IL-2rE	NULL
(	NULL
position	NULL
-1383	NULL
to	NULL
-1299	NULL
)	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Four	NULL
out	NULL
of	NULL
five	NULL
putative	NULL
regulatory	NULL
elements	NULL
present	NULL
in	NULL
the	NULL
human	NULL
gene	NULL
are	NULL
conserved	NULL
in	NULL
the	NULL
mouse	NULL
:	NULL
two	NULL
GAS	NULL
sites	NULL
,	NULL
GASd	NULL
[	NULL
TTC	NULL
(	NULL
N	NULL
)	NULL
,	NULL
GAA	NULL
]	NULL
and	NULL
GASp	NULL
[	NULL
TT	NULL
(	NULL
N	NULL
)	NULL
;	NULL
AA	NULL
)	NULL
(	NULL
61	NULL
)	NULL
,	NULL
a	NULL
GATA	NULL
site	NULL
(	NULL
WGATAR	NULL
)	NULL
(	NULL
30	NULL
)	NULL
which	NULL
overlaps	NULL
with	NULL
GASp	NULL
and	NULL
the	NULL
proximal	NULL
EBS	NULL
consensus	NULL
site	NULL
(	NULL
AGGAA	NULL
)	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
mouse	NULL
gene	NULL
has	NULL
shown	NULL
that	NULL
these	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
IL-2rE	NULL
function	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
distal	NULL
human	NULL
GAS	NULL
element	NULL
(	NULL
GASd	NULL
)	NULL
overlaps	NULL
with	NULL
another	NULL
EBS	NULL
motif	NULL
(	NULL
EBSd	NULL
)	NULL
.	NULL

In	NULL
the	NULL
mouse	NULL
sequence	NULL
,	NULL
the	NULL
EBSd	NULL
is	NULL
disrupted	NULL
by	NULL
an	NULL
inversion	NULL
(	NULL
AdG	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
PRRIII	NULL
,	NULL
a	NULL
new	NULL
positive	NULL
regulatory	NULL
region	NULL
in	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

We	NULL
screened	NULL
the	NULL
human	NULL
IL-2Ra	NULL
-flanking	NULL
region	NULL
for	NULL
regulatory	NULL
elements	NULL
,	NULL
upstream	NULL
of	NULL
PRRI	NULL
6832	NULL
LECINE	NULL
ET	NULL
AL	NULL
.	NULL

(	NULL
5-3	NULL
)	NULL
(	NULL
53	NULL
)	NULL
pTK4	NULL
2.50	NULL
3.00	NULL
3.50	NULL
4.090	NULL
4.50	NULL
5.00	NULL
5.50	NULL
IL-2	NULL
induction	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
IL-2rE	NULL
segment	NULL
.	NULL

Kit225	NULL
T	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
20	NULL
h	NULL
and	NULL
transfected	NULL
with	NULL
various	NULL
constructions	NULL
containing	NULL
the	NULL
putative	NULL
human	NULL
IL-2rE	NULL
.	NULL

The	NULL
plasmid	NULL
pCMV-CAT	NULL
was	NULL
used	NULL
to	NULL
control	NULL
the	NULL
physiological	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
after	NULL
IL-2	NULL
starvation	NULL
and	NULL
IL-2	NULL
stimulation	NULL
.	NULL

pCMV-CAT	NULL
was	NULL
strongly	NULL
expressed	NULL
and	NULL
not	NULL
affected	NULL
by	NULL
IL-2	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
control	NULL
IL-2	NULL
induction	NULL
,	NULL
we	NULL
used	NULL
the	NULL
plasmid	NULL
GRR3	NULL
,	NULL
which	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
FoyRI	NULL
GAS	NULL
site	NULL
.	NULL

Expression	NULL
of	NULL
this	NULL
plasmid	NULL
was	NULL
increased	NULL
10-	NULL
to	NULL
20-fold	NULL
by	NULL
IL-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

pTK4	NULL
,	NULL
HSV	NULL
TK	NULL
minimal	NULL
promoter	NULL
CAT	NULL
construct	NULL
;	NULL
pTK4/250	NULL
(	NULL
5'-	NULL
>	NULL
3	NULL
'	NULL
)	NULL
,	NULL
250-nucleotide	NULL
Xbel	NULL
fragment	NULL
(	NULL
nucleotides	NULL
-4260	NULL
to	NULL
-4010	NULL
)	NULL
inserted	NULL
upstream	NULL
of	NULL
HSV	NULL
TK	NULL
promoter	NULL
into	NULL
pTK4	NULL
in	NULL
its	NULL
natural	NULL
orientation	NULL
;	NULL
pTK4/250	NULL
(	NULL
3'-5	NULL
'	NULL
)	NULL
,	NULL
250-nucleotide	NULL
Xbal	NULL
fragment	NULL
inserted	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
into	NULL
pTK4	NULL
;	NULL
pTK4/963	NULL
(	NULL
5'-3	NULL
'	NULL
)	NULL
,	NULL
Pvull/SphI	NULL
fragment	NULL
(	NULL
nucleotides	NULL
-4473	NULL
to	NULL
-3510	NULL
)	NULL
inserted	NULL
into	NULL
pTK4	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
are	NULL
the	NULL
means	NULL
of	NULL
four	NULL
independent	NULL
determinations	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
represent	NULL
standard	NULL
deviations	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

and	NULL
PRRII	NULL
,	NULL
by	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
a	NULL
series	NULL
of	NULL
fragments	NULL
derived	NULL
from	NULL
the	NULL
8.5-kb	NULL
fragment	NULL
between	NULL
nucleotides	NULL
-9365	NULL
and	NULL
-1238	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
gene	NULL
(	NULL
HSV	NULL
TK	NULL
)	NULL
in	NULL
pTK4-CAT	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
these	NULL
constructs	NULL
was	NULL
tested	NULL
in	NULL
the	NULL
IL-2-dependent	NULL
human	NULL
Kit225	NULL
cell	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
revealed	NULL
that	NULL
a	NULL
250-nucleotide	NULL
Xbal	NULL
fragment	NULL
conferred	NULL
transcriptional	NULL
responsiveness	NULL
to	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
induction	NULL
was	NULL
observed	NULL
when	NULL
this	NULL
fragment	NULL
was	NULL
inserted	NULL
in	NULL
reverse	NULL
orientation	NULL
and	NULL
with	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
963-nucleotide	NULL
Pvull/SphI	NULL
fragment	NULL
that	NULL
includes	NULL
the	NULL
Xbel	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
identify	NULL
a	NULL
novel	NULL
positive	NULL
cis-acting	NULL
regulatory	NULL
region	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
,	NULL
and	NULL
they	NULL
show	NULL
that	NULL
this	NULL
region	NULL
acts	NULL
as	NULL
an	NULL
IL-2rE	NULL
like	NULL
its	NULL
murine	NULL
counterpart	NULL
.	NULL

In	NULL
line	NULL
with	NULL
the	NULL
designation	NULL
introduced	NULL
by	NULL
John	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
,	NULL
we	NULL
call	NULL
this	NULL
element	NULL
PRRIII	NULL
.	NULL

It	NULL
does	NULL
not	NULL
have	NULL
any	NULL
enhancer	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
nor	NULL
does	NULL
it	NULL
confer	NULL
responsiveness	NULL
to	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Constitutive	NULL
and	NULL
inducible	NULL
factors	NULL
bind	NULL
to	NULL
PRRIII	NULL
elements	NULL
in	NULL
vitro	NULL
.	NULL

Factors	NULL
binding	NULL
to	NULL
PRRIII	NULL
were	NULL
identified	NULL
by	NULL
EMSAs	NULL
with	NULL
whole-cell	NULL
extracts	NULL
from	NULL
unstimulated	NULL
and	NULL
IL-2-stimulated	NULL
Kit225	NULL
cells	NULL
and	NULL
different	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
the	NULL
putative	NULL
GAS	NULL
,	NULL
EBS	NULL
,	NULL
and	NULL
GATA	NULL
elements	NULL
.	NULL

Since	NULL
among	NULL
these	NULL
three	NULL
putative	NULL
regulatory	NULL
elements	NULL
,	NULL
only	NULL
the	NULL
GAS	NULL
sites	NULL
are	NULL
known	NULL
to	NULL
bind	NULL
IL-2-induced	NULL
transcription	NULL
factors	NULL
(	NULL
4	NULL
,	NULL
19	NULL
,	NULL
73	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
GAS-containing	NULL
probes	NULL
to	NULL
bind	NULL
Stat	NULL
proteins	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
family	NULL
directly	NULL
involved	NULL
in	NULL
IL-2	NULL
signal	NULL
transduction	NULL
.	NULL

One	NULL
constitutive	NULL
(	NULL
C1	NULL
)	NULL
and	NULL
two	NULL
IL-2-induced	NULL
(	NULL
C2	NULL
and	NULL
C3	NULL
)	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
identified	NULL
with	NULL
the	NULL
human	NULL
GASd/EBSd	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

C2	NULL
and	NULL
C3	NULL
were	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
5	NULL
min	NULL
after	NULL
IL-2	NULL
addition	NULL
and	NULL
persisted	NULL
up	NULL
to	NULL
30	NULL
min	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
inducible	NULL
complex	NULL
was	NULL
revealed	NULL
with	NULL
the	NULL
GASp/GATA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
described	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
FeyRI-GAS	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
GAS	NULL
d	NULL
GAS	NULL
p	NULL
FoyRI	NULL
min	NULL
:	NULL
_	NULL
0	NULL
5	NULL
15	NULL
30	NULL
0	NULL
5	NULL
15	NULL
30	NULL
0	NULL
5	NULL
15	NULL
30	NULL
dhe	NULL
cmm	NULL
diem	NULL
coh	NULL
Cs	NULL
I	NULL
>	NULL
tms	NULL
Gung	NULL
Game	NULL
<	NULL
G	NULL
C2	NULL
Ip	NULL
tind	NULL
Aumat	NULL
Sut	NULL
ci	NULL
Wth	NULL
but	NULL
bb	NULL
fot	NULL
1	NULL
20	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
B	NULL
GAS	NULL
d	NULL
4	NULL
&	NULL
«	NULL
o_	NULL
_a	NULL
4	NULL
#	NULL
4	NULL
4	NULL
C3	NULL
Ip	NULL
haved	NULL
toa	NULL
bicut	NULL
Ned	NULL
C2	NULL
I	NULL
>	NULL
``	NULL
Ci	NULL
+=	NULL
\d	NULL
-	NULL
post	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

In	NULL
vitro	NULL
complexes	NULL
formed	NULL
by	NULL
GASd/EBSd	NULL
,	NULL
GASp/GATA	NULL
,	NULL
and	NULL
FeyRI-GAS	NULL
sites	NULL
,	NULL
detected	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IL-2-deprived	NULL
Kit225	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
and	NULL
harvested	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
.	NULL

Then	NULL
,	NULL
8	NULL
pl	NULL
of	NULL
whole-cell	NULL
extracts	NULL
was	NULL
incubated	NULL
with	NULL
``	NULL
P-labeled	NULL
probes	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cpm	NULL
per	NULL
reaction	NULL
)	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
are	NULL
analyzed	NULL
in	NULL
nondenaturing	NULL
acrylamide	NULL
gels	NULL
and	NULL
revealed	NULL
by	NULL
autoradiography	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Identification	NULL
of	NULL
the	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
by	NULL
competition	NULL
experiments	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
Kit225	NULL
cells	NULL
,	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
IL-2	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
7	NULL
)	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
IL-2R	NULL
«	NULL
-GASd/EBSd	NULL
probe	NULL
by	NULL
using	NULL
Stat-binding	NULL
conditions	NULL
.	NULL

Competitions	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
100	NULL
%	NULL
excess	NULL
of	NULL
the	NULL
following	NULL
unlabeled	NULL
competitors	NULL
:	NULL
wild-type	NULL
IL-2R	NULL
«	NULL
-GASd/EBSd	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
wt	NULL
)	NULL
;	NULL
IL-2Ro-m1GASd	NULL
(	NULL
GASd	NULL
mut	NULL
,	NULL
mutated	NULL
in	NULL
the	NULL
GASd	NULL
site	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
IL-2Ra-mEBSd	NULL
(	NULL
EBS	NULL
mut	NULL
,	NULL
mutated	NULL
in	NULL
the	NULL
EBSd	NULL
site	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
IL-2Ro-m2GASd	NULL
gave	NULL
the	NULL
same	NULL
result	NULL
as	NULL
that	NULL
obtained	NULL
with	NULL
IL-2Ra-m1GASd	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
putative	NULL
involvement	NULL
of	NULL
Ets-related	NULL
proteins	NULL
in	NULL
the	NULL
complexes	NULL
revealed	NULL
by	NULL
the	NULL
GASd/RBSd	NULL
probes	NULL
,	NULL
competition	NULL
with	NULL
a	NULL
100	NULL
%	NULL
excess	NULL
of	NULL
a	NULL
high-affinity	NULL
EBS	NULL
binding	NULL
site	NULL
(	NULL
EBSa	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
with	NULL
a	NULL
nonbinding	NULL
mutant	NULL
(	NULL
EBSz	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
was	NULL
performed	NULL
.	NULL

probe	NULL
revealed	NULL
only	NULL
two	NULL
inducible	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
proteins	NULL
forming	NULL
complexes	NULL
with	NULL
the	NULL
GASd/EBSd	NULL
probe	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
competitors	NULL
for	NULL
Stat	NULL
and	NULL
Ets	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
unlabeled	NULL
wild-type	NULL
GASd/EBSd	NULL
abolished	NULL
both	NULL
inducible	NULL
complexes	NULL
(	NULL
C2	NULL
and	NULL
C3	NULL
)	NULL
but	NULL
hardly	NULL
affected	NULL
the	NULL
constitutive	NULL
complex	NULL
(	NULL
C1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
two	NULL
mutant	NULL
GASd/	NULL
EBSd	NULL
oligonucleotides	NULL
,	NULL
in	NULL
which	NULL
the	NULL
GAS	NULL
but	NULL
not	NULL
the	NULL
EBS	NULL
motif	NULL
was	NULL
disrupted	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
C2	NULL
and	NULL
C3	NULL
but	NULL
almost	NULL
abolished	NULL
C1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
containing	NULL
an	NULL
intact	NULL
GAS	NULL
and	NULL
a	NULL
disrupted	NULL
EBS	NULL
motif	NULL
had	NULL
the	NULL
same	NULL
effect	NULL
as	NULL
the	NULL
wild-type	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

C2	NULL
and	NULL
C3	NULL
were	NULL
efficiently	NULL
competed	NULL
by	NULL
a	NULL
100	NULL
%	NULL
excess	NULL
of	NULL
unlabeled	NULL
FeyRI	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
100	NULL
%	NULL
excess	NULL
of	NULL
the	NULL
EBSa	NULL
oligonucleotide	NULL
completely	NULL
abolished	NULL
C1	NULL
without	NULL
affecting	NULL
the	NULL
inducible	NULL
C2	NULL
and	NULL
C3	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
EBSz	NULL
competitor	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
any	NULL
of	NULL
the	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Together	NULL
our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
IL-2-induced	NULL
C2	NULL
and	NULL
C3	NULL
complexes	NULL
are	NULL
due	NULL
to	NULL
the	NULL
GAS	NULL
consensus	NULL
sequence	NULL
present	NULL
within	NULL
the	NULL
human	NULL
GASd/EBSd	NULL
element	NULL
while	NULL
the	NULL
constitutive	NULL
C1	NULL
complex	NULL
depends	NULL
on	NULL
the	NULL
EBSd	NULL
motif	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
EBSa	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
high-affinity	NULL
Ets-binding	NULL
site	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
C1	NULL
much	NULL
more	NULL
efficiently	NULL
than	NULL
the	NULL
GASd/	NULL
EBSd	NULL
oligonucleotide	NULL
itself	NULL
suggests	NULL
that	NULL
the	NULL
GASd/EBSd	NULL
is	NULL
a	NULL
low-affinity	NULL
binding	NULL
site	NULL
for	NULL
Ets	NULL
proteins	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
constitutive	NULL
and	NULL
IL-2-induced	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
human	NULL
GASd/EBSd	NULL
element	NULL
.	NULL

Since	NULL
IL-2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
Stat5	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
the	NULL
inducible	NULL
complexes	NULL
present	NULL
in	NULL
IL-2-treated	NULL
Kit225	NULL
cells	NULL
contain	NULL
Stat5-related	NULL
proteins	NULL
.	NULL

Supershift	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
two	NULL
antisera	NULL
recognizing	NULL
Stat5	NULL
.	NULL

Addition	NULL
of	NULL
anti-sheep	NULL
MGF/StatSa	NULL
(	NULL
17	NULL
)	NULL
,	NULL
a	NULL
serum	NULL
that	NULL
recognizes	NULL
preferentially	NULL
Stat5a	NULL
in	NULL
supershift	NULL
assays	NULL
(	NULL
16a	NULL
)	NULL
,	NULL
to	NULL
binding	NULL
reactions	NULL
with	NULL
Kit225	NULL
extracts	NULL
and	NULL
the	NULL
GASd/EBSd	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
did	NULL
not	NULL
result	NULL
in	NULL
a	NULL
clear	NULL
supershift	NULL
of	NULL
any	NULL
of	NULL
the	NULL
specific	NULL
complexes	NULL
,	NULL
while	NULL
the	NULL
same	NULL
antiserum	NULL
efficiently	NULL
supershifted	NULL
the	NULL
complexes	NULL
formed	NULL
by	NULL
cytoplasmic	NULL
extracts	NULL
of	NULL
IL-3-stimulated	NULL
Ba/F3	NULL
and	NULL
the	NULL
GASd/EBSd	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
anti-Stat5	NULL
serum	NULL
C-17	NULL
,	NULL
which	NULL
recognizes	NULL
both	NULL
StatSa	NULL
and	NULL
b	NULL
,	NULL
supershifted	NULL
almost	NULL
completely	NULL
the	NULL
two	NULL
inducible	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
EBS-binding	NULL
proteins	NULL
in	NULL
the	NULL
C1	NULL
complex	NULL
,	NULL
supershift	NULL
experiments	NULL
with	NULL
unstimulated	NULL
whole-cell	NULL
extracts	NULL
from	NULL
Kit225	NULL
and	NULL
commercial	NULL
Elf-1-	NULL
,	NULL
Ets-1/2-	NULL
,	NULL
or	NULL
Stat3-specific	NULL
antisera	NULL
were	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

A	NULL
partial	NULL
but	NULL
reproducible	NULL
supershift	NULL
with	NULL
anti-Elf-1	NULL
serum	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
commercially	NULL
available	NULL
Ets-1/2	NULL
and	NULL
Stat3	NULL
antisera	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
C1	NULL
complexes	NULL
contained	NULL
Elf-1	NULL
.	NULL

Additional	NULL
supershift	NULL
experiments	NULL
with	NULL
different	NULL
antisera	NULL
directed	NULL
against	NULL
Ets-1/2	NULL
(	NULL
#	NULL
8	NULL
)	NULL
,	NULL
Fli-1	NULL
(	NULL
#	NULL
61	NULL
)	NULL
,	NULL
or	NULL
Tel	NULL
(	NULL
#	NULL
69	NULL
)	NULL
(	NULL
2	NULL
,	NULL
55	NULL
)	NULL
,	NULL
showed	NULL
that	NULL
the	NULL
anti-Ets1/2	NULL
and	NULL
-Fli-1	NULL
reagents	NULL
partially	NULL
supershifted	NULL
complex	NULL
C1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
anti-Tel	NULL
antibodies	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

An	NULL
anti-Elf-1	NULL
monoclonal	NULL
antibody	NULL
(	NULL
81	NULL
)	NULL
gave	NULL
the	NULL
same	NULL
pattern	NULL
as	NULL
the	NULL
commercial	NULL
anti-Elf-1	NULL
polyclonal	NULL
serum	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
among	NULL
the	NULL
Ets	NULL
family	NULL
members	NULL
tested	NULL
,	NULL
Elf-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and/or	NULL
Ets-2	NULL
and	NULL
Fli-1	NULL
may	NULL
all	NULL
contribute	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
C1	NULL
.	NULL

As	NULL
an	NULL
alternative	NULL
method	NULL
to	NULL
identify	NULL
the	NULL
Stat5	NULL
and	NULL
Ets	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
GASd/EBSd	NULL
motif	NULL
,	NULL
we	NULL
used	NULL
biotinylated	NULL
oligonucleotide	NULL
probes	NULL
to	NULL
affinity	NULL
purify	NULL
proteins	NULL
from	NULL
Kit225	NULL
and	NULL
PBMC	NULL
whole-cell	NULL
extracts	NULL
.	NULL

The	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
GASd/EBSd	NULL
or	NULL
the	NULL
FeyRI	NULL
oligonucleotide	NULL
were	NULL
Western	NULL
blotted	NULL
and	NULL
analyzed	NULL
with	NULL
various	NULL
Stat5-	NULL
and	NULL
Ets-specific	NULL
antisera	NULL
.	NULL

These	NULL
assays	NULL
revealed	NULL
that	NULL
Elf-1	NULL
bound	NULL
to	NULL
the	NULL
GASd/EBSd	NULL
probe	NULL
but	NULL
not	NULL
the	NULL
FeyRI	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
and	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

Elf-1	NULL
binding	NULL
was	NULL
constitutive	NULL
and	NULL
unaffected	NULL
by	NULL
IL-2	NULL
.	NULL

The	NULL
anti-Ets-1/2	NULL
,	NULL
-Fli-1	NULL
,	NULL
and	NULL
-Tel	NULL
sera	NULL
Jak-Stat	NULL
ACTIVATION	NULL
OF	NULL
IL-2Re	NULL
«	NULL
GENE	NULL
6833	NULL
showed	NULL
no	NULL
specific	NULL
reaction	NULL
with	NULL
any	NULL
proteins	NULL
on	NULL
the	NULL
same	NULL
blots	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
only	NULL
a	NULL
small	NULL
fraction	NULL
of	NULL
complex	NULL
C1	NULL
was	NULL
supershifted	NULL
by	NULL
the	NULL
anti-Ets1/2	NULL
and	NULL
anti-Fli-1	NULL
sera	NULL
,	NULL
this	NULL
suggests	NULL
that	NULL
Ets-1	NULL
and/or	NULL
-2	NULL
and	NULL
Fli-1	NULL
only	NULL
make	NULL
a	NULL
minor	NULL
contribution	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
C1	NULL
.	NULL

As	NULL
expected	NULL
IL-2	NULL
induced	NULL
Stat5b	NULL
bound	NULL
to	NULL
the	NULL
GASd/EBSd	NULL
probe	NULL
,	NULL
but	NULL
we	NULL
failed	NULL
to	NULL
detect	NULL
StatSa	NULL
proteins	NULL
in	NULL
Kit225	NULL
cell	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
this	NULL
result	NULL
was	NULL
due	NULL
to	NULL
an	NULL
unexpected	NULL
difference	NULL
between	NULL
the	NULL
binding	NULL
specificities	NULL
of	NULL
StatSa	NULL
and	NULL
b	NULL
or	NULL
a	NULL
particularly	NULL
of	NULL
Kit225	NULL
cells	NULL
,	NULL
the	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
whole-cell	NULL
extracts	NULL
from	NULL
IL-2-stimulated	NULL
PHA	NULL
blasts	NULL
.	NULL

IL-2	NULL
stimulation	NULL
induced	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
both	NULL
StatSa	NULL
and	NULL
StatSb	NULL
proteins	NULL
to	NULL
the	NULL
GASd/EBSd	NULL
and	NULL
the	NULL
FoeyRI	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Together	NULL
these	NULL
experiments	NULL
demonstrate	NULL
that	NULL
both	NULL
StatSa	NULL
and	NULL
b	NULL
proteins	NULL
can	NULL
bind	NULL
the	NULL
GASd	NULL
site	NULL
of	NULL
the	NULL
human	NULL
PRRIII	NULL
and	NULL
that	NULL
the	NULL
IL-2-induced	NULL
C2	NULL
and	NULL
C3	NULL
complexes	NULL
in	NULL
Kit225	NULL
cell	NULL
extracts	NULL
contain	NULL
StatSb	NULL
proteins	NULL
.	NULL

Our	NULL
observations	NULL
also	NULL
show	NULL
that	NULL
Elf-1	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
GASd/EBSd	NULL
site	NULL
and	NULL
confirm	NULL
its	NULL
presence	NULL
in	NULL
the	NULL
constitutive	NULL
complex	NULL
C1	NULL
.	NULL

IL-2	NULL
stimulation	NULL
of	NULL
Kit225	NULL
T	NULL
cells	NULL
and	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
human	NULL
primary	NULL
T	NULL
cells	NULL
result	NULL
in	NULL
the	NULL
in	NULL
vivo	NULL
occupancy	NULL
of	NULL
the	NULL
GASd/EBSd	NULL
site	NULL
within	NULL
the	NULL
PRRIII	NULL
Changes	NULL
in	NULL
the	NULL
pattern	NULL
of	NULL
in	NULL
vivo	NULL
protein-DNA	NULL
interactions	NULL
in	NULL
the	NULL
PRRIII	NULL
that	NULL
correlate	NULL
with	NULL
activation	NULL
of	NULL
the	NULL
IL-Z2Ra	NULL
locus	NULL
were	NULL
analyzed	NULL
by	NULL
ligation-mediated	NULL
PCR	NULL
footprint	NULL
assays	NULL
.	NULL

Living	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
DMS	NULL
,	NULL
which	NULL
methylates	NULL
G	NULL
residues	NULL
in	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
DNA	NULL
and	NULL
to	NULL
some	NULL
extent	NULL
A	NULL
residues	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
(	NULL
40	NULL
)	NULL
.	NULL

DNA-binding	NULL
proteins	NULL
can	NULL
protect	NULL
nucleotides	NULL
in	NULL
the	NULL
binding	NULL
site	NULL
from	NULL
being	NULL
,	NULL
or	NULL
make	NULL
bases	NULL
in	NULL
or	NULL
around	NULL
the	NULL
binding	NULL
site	NULL
,	NULL
hypersensitive	NULL
to	NULL
methylation	NULL
.	NULL

Kit225	NULL
cells	NULL
,	NULL
exponentially	NULL
growing	NULL
or	NULL
IL-2	NULL
starved	NULL
for	NULL
48	NULL
h	NULL
,	NULL
were	NULL
treated	NULL
with	NULL
DMS	NULL
and	NULL
harvested	NULL
.	NULL

Their	NULL
DNA	NULL
was	NULL
isolated	NULL
and	NULL
used	NULL
for	NULL
LM-PCR	NULL
footprinting	NULL
.	NULL

The	NULL
most	NULL
striking	NULL
difference	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
populations	NULL
was	NULL
the	NULL
disappearance	NULL
,	NULL
upon	NULL
IL-2	NULL
starvation	NULL
,	NULL
of	NULL
the	NULL
protection	NULL
of	NULL
the	NULL
G	NULL
residue	NULL
at	NULL
position	NULL
-4176	NULL
within	NULL
GASd/EBSd	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
of	NULL
the	NULL
two	NULL
G	NULL
residues	NULL
-4175	NULL
and	NULL
-4176	NULL
,	NULL
only	NULL
the	NULL
latter	NULL
appears	NULL
to	NULL
be	NULL
methylated	NULL
by	NULL
DMS	NULL
.	NULL

This	NULL
is	NULL
true	NULL
also	NULL
for	NULL
in	NULL
vitro	NULL
methylation	NULL
of	NULL
naked	NULL
DNA	NULL
.	NULL

At	NULL
present	NULL
we	NULL
have	NULL
no	NULL
explanation	NULL
of	NULL
this	NULL
phenomenon	NULL
.	NULL

Intriguingly	NULL
,	NULL
a	NULL
similar	NULL
insensitivity	NULL
to	NULL
methylation	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
the	NULL
G	NULL
residue	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
that	NULL
is	NULL
homologous	NULL
to	NULL
residue	NULL
-4175	NULL
.	NULL

IL-2-dependent	NULL
protection	NULL
of	NULL
G-4176	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
active	NULL
Stat5b	NULL
in	NULL
IL-2-stimulated	NULL
but	NULL
not	NULL
in	NULL
IL-2-deprived	NULL
Kit225	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
constitutive	NULL
protection	NULL
of	NULL
G	NULL
residues	NULL
-4182	NULL
and	NULL
-4179	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
in	NULL
vivo	NULL
occupation	NULL
of	NULL
the	NULL
GASd/EBSd	NULL
site	NULL
by	NULL
the	NULL
constitutively	NULL
active	NULL
ETS	NULL
proteins	NULL
revealed	NULL
in	NULL
the	NULL
EMSA	NULL
experiments	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
G	NULL
residue	NULL
-4159	NULL
in	NULL
the	NULL
GASp/GATA	NULL
site	NULL
was	NULL
also	NULL
protected	NULL
in	NULL
both	NULL
IL-2-starved	NULL
and	NULL
IL-2-induced	NULL
Kit225	NULL
cells	NULL
,	NULL
as	NULL
expected	NULL
from	NULL
the	NULL
characterization	NULL
of	NULL
constitutive	NULL
DNA-protein	NULL
complexes	NULL
by	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
these	NULL
differences	NULL
could	NULL
be	NULL
directly	NULL
correlated	NULL
with	NULL
Stat5	NULL
activation	NULL
by	NULL
IL-2	NULL
,	NULL
the	NULL
same	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
cells	NULL
treated	NULL
for	NULL
different	NULL
times	NULL
with	NULL
IL-2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
partial	NULL
protection	NULL
of	NULL
the	NULL
G	NULL
residue	NULL
at	NULL
position	NULL
-4176	NULL
was	NULL
observed	NULL
as	NULL
soon	NULL
as	NULL
30	NULL
min	NULL
after	NULL
IL-2	NULL
addition	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
physiological	NULL
relevance	NULL
of	NULL
these	NULL
observa-tions	NULL
,	NULL
LM-PCR	NULL
genomic	NULL
footprint	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
harvested	NULL
after	NULL
different	NULL
times	NULL
of	NULL
stimulation	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
CD2	NULL
and	NULL
CD28	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
this	NULL
strong	NULL
mitogenic	NULL
stimulus	NULL
,	NULL
which	NULL
triggers	NULL
long-term	NULL
IL-2-dependent	NULL
activation	NULL
of	NULL
resting	NULL
T	NULL
lymphocytes	NULL
(	NULL
49	NULL
)	NULL
,	NULL
induced	NULL
protection	NULL
of	NULL
G-4176	NULL
in	NULL
the	NULL
GASd/EBSd	NULL
site	NULL
.	NULL

Protection	NULL
persisted	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

6834	NULL
LECINE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
GAS	NULL
d	NULL
B	NULL
a	NULL
4	NULL
.	NULL

4.	NULL
io	NULL
TV	NULL
ya	NULL
,	NULL
~	NULL
é	NULL
,	NULL
g	NULL
55	NULL
?	NULL

®	NULL
%	NULL
&	NULL
&	NULL
&	NULL
R	NULL
<	NULL
D	NULL
>	NULL
¥	NULL
C	NULL
se-	NULL
WP	NULL
&	NULL
»	NULL
C2	NULL
P	NULL
%	NULL
C1	NULL
P	NULL
(	NULL
eal	NULL
3	NULL
)	NULL
ina	NULL
»	NULL
‘	NULL
l	NULL
'	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
GAS	NULL
d	NULL
GAS	NULL
d	NULL
el	NULL
n	NULL
%	NULL
©	NULL
O	NULL
v	NULL
Y	NULL
-	NULL
p	NULL
v	NULL
--	NULL
_-_-_P	NULL
6	NULL
“	NULL
ﬁbgéﬁ	NULL
Vex/ﬁgﬂg	NULL
‘	NULL
*	NULL
Fo	NULL
soo	NULL
#	NULL
¥	NULL
¥	NULL
§	NULL
f	NULL
L	NULL
p	NULL
>	NULL
bus	NULL
p	NULL
>	NULL
tim	NULL
es	NULL
Win	NULL
bs	NULL
5	NULL
6	NULL
7	NULL
8	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
GASd/EBSd	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Radiolabeled	NULL
IL-2R	NULL
«	NULL
-GASd/EBSd	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
whole-cell	NULL
extracts	NULL
from	NULL
IL-2-deprived	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
IL-2-stimulated	NULL
(	NULL
30	NULL
min	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
Kit225	NULL
cells	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
without	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
directed	NULL
against	NULL
StatSa	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
both	NULL
Stat5a	NULL
and	NULL
b	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
proteins	NULL
.	NULL

Anti-MGF	NULL
,	NULL
/StatSa	NULL
serum	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
when	NULL
compared	NULL
with	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Anti-Stat5	NULL
serum	NULL
C-17	NULL
,	NULL
which	NULL
recognizes	NULL
Stat5a	NULL
and	NULL
b	NULL
proteins	NULL
,	NULL
supershifted	NULL
both	NULL
inducible	NULL
complexes	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
To	NULL
test	NULL
the	NULL
involvement	NULL
of	NULL
Ets	NULL
proteins	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
constitutive	NULL
complex	NULL
C1	NULL
,	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
P-labeled	NULL
IL-2R	NULL
«	NULL
-GASd/EBSd	NULL
probe	NULL
and	NULL
whole-cell	NULL
extracts	NULL
from	NULL
IL-2	NULL
deprived	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
Kit225	NULL
cells	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
directed	NULL
against	NULL
different	NULL
Ets	NULL
proteins	NULL
.	NULL

The	NULL
following	NULL
antisera	NULL
were	NULL
used	NULL
:	NULL
anti-Elf-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
anti-Ets1/2	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
anti-Stat3	NULL
(	NULL
UBI	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
anti-Ets1/2	NULL
#	NULL
8	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
anti-Fli-1	NULL
#	NULL
61	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
and	NULL
anti-Tel	NULL
#	NULL
69	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

The	NULL
constitutive	NULL
complex	NULL
was	NULL
partially	NULL
supershifted	NULL
with	NULL
the	NULL
anti-Elf-1	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
the	NULL
anti-Ets1/2	NULL
#	NULL
8	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
and	NULL
the	NULL
anti-Fli-1	NULL
#	NULL
61	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Filled	NULL
arrowheads	NULL
,	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
;	NULL
open	NULL
arrowheads	NULL
,	NULL
position	NULL
of	NULL
the	NULL
complexes	NULL
supershifted	NULL
by	NULL
the	NULL
specific	NULL
antisera	NULL
.	NULL

Stars	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
complexes	NULL
due	NULL
to	NULL
nonspecific	NULL
DNA-binding	NULL
activities	NULL
(	NULL
not	NULL
competed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
unlabeled	NULL
GASd/EBSd	NULL
oligonucleotide	NULL
)	NULL
in	NULL
the	NULL
sera	NULL
.	NULL

up	NULL
to	NULL
96	NULL
h	NULL
of	NULL
stimulation	NULL
.	NULL

Constitutive	NULL
occupancy	NULL
of	NULL
the	NULL
site	NULL
was	NULL
also	NULL
observed	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
GASd/EBSd	NULL
element	NULL
is	NULL
essential	NULL
for	NULL
IL-2	NULL
inducibility	NULL
and	NULL
Stat5	NULL
can	NULL
transactivate	NULL
the	NULL
PRRIII	NULL
element	NULL
whereas	NULL
Elf-1	NULL
can	NULL
serve	NULL
as	NULL
a	NULL
repressor	NULL
in	NULL
Kit225	NULL
cells	NULL
.	NULL

To	NULL
test	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
overlapping	NULL
nuclear	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
GASd/	NULL
EBSd	NULL
element	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
the	NULL
PRRIII	NULL
enhancer	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
response	NULL
of	NULL
pTK4-CAT/250	NULL
,	NULL
containing	NULL
the	NULL
250-nucleotide	NULL
Xbael	NULL
fragment	NULL
that	NULL
includes	NULL
PRRIII	NULL
,	NULL
with	NULL
that	NULL
of	NULL
two	NULL
mutants	NULL
.	NULL

In	NULL
one	NULL
of	NULL
these	NULL
,	NULL
the	NULL
GASd	NULL
element	NULL
was	NULL
disrupted	NULL
(	NULL
5	NULL
)	NULL
while	NULL
the	NULL
other	NULL
contained	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
overlapping	NULL
EBS	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
PRRIII	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
CAT	NULL
expression	NULL
vector	NULL
with	NULL
the	NULL
minimal	NULL
HSV	NULL
TK	NULL
promoter	NULL
.	NULL

These	NULL
constructs	NULL
as	NULL
well	NULL
as	NULL
the	NULL
pTK4	NULL
vector	NULL
were	NULL
tested	NULL
for	NULL
enhancer	NULL
activity	NULL
by	NULL
transient	NULL
transfection	NULL
into	NULL
Kit225	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
20	NULL
h.	NULL
After	NULL
transfection	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
for	NULL
16	NULL
h.	NULL
The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
show	NULL
that	NULL
disruption	NULL
of	NULL
the	NULL
GASd	NULL
site	NULL
abolished	NULL
IL-2	NULL
inducibility	NULL
,	NULL
strongly	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
Stat5b	NULL
in	NULL
the	NULL
IL-2	NULL
response	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
EBSd	NULL
mutation	NULL
significantly	NULL
increased	NULL
basal	NULL
CAT	NULL
activity	NULL
.	NULL

Expression	NULL
of	NULL
this	NULL
plasmid	NULL
after	NULL
IL-2	NULL
stimulation	NULL
was	NULL
close	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
construct	NULL
,	NULL
but	NULL
induction	NULL
by	NULL
IL-2	NULL
was	NULL
only	NULL
marginal	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
protein	NULL
binding	NULL
constitutively	NULL
to	NULL
the	NULL
EBSd	NULL
site	NULL
may	NULL
act	NULL
as	NULL
a	NULL
repressor	NULL
.	NULL

IL-2	NULL
stimulation	NULL
may	NULL
relieve	NULL
repression	NULL
through	NULL
the	NULL
binding	NULL
of	NULL
Stat5	NULL
to	NULL
the	NULL
overlapping	NULL
GAS	NULL
site	NULL
.	NULL

This	NULL
model	NULL
is	NULL
consistent	NULL
with	NULL
all	NULL
the	NULL
data	NULL
so	NULL
far	NULL
presented	NULL
in	NULL
this	NULL
paper	NULL
.	NULL

To	NULL
obtain	NULL
more	NULL
direct	NULL
evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
Stat5	NULL
and	NULL
Elf-1	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
regulators	NULL
of	NULL
PRRIII	NULL
enhancer	NULL
activ-	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
FoyRI	NULL
#	NULL
6	NULL
w	NULL
v	NULL
JY	NULL
$	NULL
4	NULL
J	NULL
S4	NULL
A	NULL
fue	NULL
of	NULL
women	NULL
StatSa	NULL
B	NULL
Grennmet	NULL
:	NULL
*	NULL
*	NULL
%	NULL
#	NULL
StatSb	NULL
C	NULL
wes	NULL
taps	NULL
00	NULL
|	NULL
Eif-1	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Identification	NULL
,	NULL
by	NULL
DNA	NULL
affinity	NULL
purification	NULL
,	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
GASd/EBSd	NULL
and	NULL
FoyRI	NULL
sites	NULL
.	NULL

Oligoprecipitations	NULL
of	NULL
FeyRI-GAS-	NULL
and	NULL
GASd/EBSd-bound	NULL
proteins	NULL
with	NULL
PBMC	NULL
were	NULL
activated	NULL
with	NULL
PHA	NULL
for	NULL
3	NULL
days	NULL
and	NULL
then	NULL
arrested	NULL
by	NULL
culturing	NULL
them	NULL
in	NULL
medium	NULL
without	NULL
stimulation	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
then	NULL
cultured	NULL
for	NULL
30	NULL
min	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
with	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
and	NULL
5	NULL
and	NULL
6	NULL
)	NULL
IL-2	NULL
,	NULL
and	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Proteins	NULL
binding	NULL
to	NULL
the	NULL
biotinylated	NULL
oligonucleotides	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
were	NULL
isolated	NULL
,	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
blotted	NULL
on	NULL
membranes	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
identified	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
antisera	NULL
specific	NULL
for	NULL
the	NULL
proteins	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
side	NULL
of	NULL
the	NULL
panels	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
a	NULL
100	NULL
%	NULL
excess	NULL
of	NULL
nonbiotinylated	NULL
wild-type	NULL
GASd/EBSd	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

ity	NULL
,	NULL
we	NULL
transfected	NULL
Kit225	NULL
cells	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
these	NULL
proteins	NULL
,	NULL
together	NULL
with	NULL
the	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
driven	NULL
by	NULL
the	NULL
human	NULL
IL-2rE	NULL
or	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
pTK4	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
neither	NULL
Stat5b	NULL
nor	NULL
Elf-1	NULL
affected	NULL
the	NULL
IL-2	NULL
nonresponsiveness	NULL
of	NULL
pTK4	NULL
.	NULL

Cotransfection	NULL
with	NULL
the	NULL
Stat5b	NULL
vector	NULL
increased	NULL
both	NULL
constitutive	NULL
and	NULL
IL-2-induced	NULL
expression	NULL
of	NULL
the	NULL
PRRIII-driven	NULL
plasmid	NULL
pTK4/250	NULL
,	NULL
resulting	NULL
in	NULL
no	NULL
significant	NULL
change	NULL
of	NULL
its	NULL
IL-2	NULL
response	NULL
.	NULL

When	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
Elf-1	NULL
vector	NULL
were	NULL
included	NULL
,	NULL
expression	NULL
of	NULL
pTK4/250	NULL
in	NULL
IL-2-treated	NULL
cells	NULL
gradually	NULL
decreased	NULL
without	NULL
any	NULL
significant	NULL
effect	NULL
on	NULL
its	NULL
constitutive	NULL
expression	NULL
.	NULL

The	NULL
net	NULL
result	NULL
was	NULL
a	NULL
virtually	NULL
complete	NULL
suppression	NULL
of	NULL
IL-2	NULL
responsiveness	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
negative	NULL
role	NULL
of	NULL
Elf-1	NULL
in	NULL
PRIII	NULL
regulation	NULL
.	NULL

Altogether	NULL
these	NULL
results	NULL
strongly	NULL
support	NULL
a	NULL
direct	NULL
involvement	NULL
of	NULL
Stat5	NULL
in	NULL
the	NULL
IL-2-dependent	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
and	NULL
indicate	NULL
that	NULL
Elf-1	NULL
may	NULL
serve	NULL
to	NULL
reduce	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
in	NULL
non-stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

DISCUSSION	NULL
The	NULL
a	NULL
chain	NULL
of	NULL
the	NULL
IL-2R	NULL
is	NULL
required	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
high-affinity	NULL
ligand	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
its	NULL
expression	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
T	NULL
lymphocytes	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
suggested	NULL
that	NULL
regulation	NULL
of	NULL
IL-Z2Ra	NULL
«	NULL
con-trols	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

This	NULL
was	NULL
validated	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
T	NULL
cells	NULL
of	NULL
transgenic	NULL
mice	NULL
constitutively	NULL
expressing	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
can	NULL
respond	NULL
to	NULL
IL-2	NULL
without	NULL
antigen	NULL
stimulation	NULL
(	NULL
47	NULL
)	NULL
.	NULL

While	NULL
antigen	NULL
is	NULL
the	NULL
primary	NULL
stimulus	NULL
inducing	NULL
IL-2Ra	NULL
transcription	NULL
,	NULL
IL-2	NULL
itself	NULL
is	NULL
required	NULL
Jak-Stat	NULL
ACTIVATION	NULL
OF	NULL
IL-2Re	NULL
«	NULL
GENE	NULL
6835	NULL
for	NULL
maximal	NULL
and	NULL
prolonged	NULL
expression	NULL
(	NULL
65	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
IL-2	NULL
increases	NULL
transcription	NULL
of	NULL
both	NULL
the	NULL
human	NULL
and	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
gene	NULL
(	NULL
11	NULL
,	NULL
54	NULL
)	NULL
,	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
elucidated	NULL
.	NULL

Signaling	NULL
by	NULL
the	NULL
IL-ZR	NULL
is	NULL
mediated	NULL
by	NULL
ligand-induced	NULL
association	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
its	NULL
IL-2RB	NULL
and	NULL
y	NULL
,	NULL
,	NULL
components	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

IL-2R	NULL
do	NULL
not	NULL
possess	NULL
intrinsic	NULL
kinase	NULL
activity	NULL
,	NULL
but	NULL
IL-2	NULL
binding	NULL
stimulates	NULL
the	NULL
activity	NULL
of	NULL
members	NULL
of	NULL
both	NULL
the	NULL
Sre	NULL
family	NULL
of	NULL
tyrosine	NULL
kinases	NULL
(	NULL
Lck	NULL
,	NULL
Fyn	NULL
,	NULL
and	NULL
Lyn	NULL
)	NULL
and	NULL
,	NULL
as	NULL
shown	NULL
more	NULL
recently	NULL
,	NULL
members	NULL
of	NULL
the	NULL
Jak	NULL
family	NULL
(	NULL
Jak1	NULL
and	NULL
Jak3	NULL
)	NULL
(	NULL
27	NULL
,	NULL
42	NULL
,	NULL
69	NULL
,	NULL
80	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
positive	NULL
regulatory	NULL
region	NULL
(	NULL
PRRIII	NULL
)	NULL
in	NULL
the	NULL
distal	NULL
S5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2R	NULL
«	NULL
gene	NULL
which	NULL
possesses	NULL
an	NULL
IL-2-dependent	NULL
enhancer	NULL
activity	NULL
.	NULL

The	NULL
strong	NULL
similarities	NULL
between	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
PRRIII	NULL
and	NULL
the	NULL
IL-2-responsive	NULL
element	NULL
in	NULL
the	NULL
mouse	NULL
IL-2R	NULL
«	NULL
gene	NULL
(	NULL
90	NULL
%	NULL
identity	NULL
)	NULL
and	NULL
between	NULL
their	NULL
cis-acting	NULL
activities	NULL
leave	NULL
no	NULL
doubt	NULL
that	NULL
these	NULL
two	NULL
elements	NULL
are	NULL
homologs	NULL
even	NULL
though	NULL
PRRIII	NULL
is	NULL
much	NULL
more	NULL
distal	NULL
(	NULL
-4.1	NULL
kb	NULL
)	NULL
than	NULL
its	NULL
mouse	NULL
counterpart	NULL
(	NULL
-1.3	NULL
kb	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
highly	NULL
homologous	NULL
proximal	NULL
regions	NULL
are	NULL
separated	NULL
from	NULL
the	NULL
PRRIII	NULL
by	NULL
segments	NULL
with	NULL
no	NULL
detectable	NULL
similarity	NULL
which	NULL
,	NULL
in	NULL
the	NULL
human	NULL
gene	NULL
,	NULL
contain	NULL
repetitive	NULL
elements	NULL
(	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
human	NULL
PRRIII	NULL
has	NULL
been	NULL
separated	NULL
from	NULL
the	NULL
promoter	NULL
proximal	NULL
region	NULL
by	NULL
one	NULL
or	NULL
more	NULL
insertions	NULL
after	NULL
the	NULL
split	NULL
between	NULL
the	NULL
evolutionary	NULL
branches	NULL
leading	NULL
to	NULL
Mus	NULL
and	NULL
Homo	NULL
.	NULL

The	NULL
results	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
lend	NULL
strong	NULL
support	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
Stats	NULL
plays	NULL
a	NULL
principal	NULL
role	NULL
in	NULL
controlling	NULL
PPRIII	NULL
activity	NULL
.	NULL

PRRIII	NULL
contains	NULL
a	NULL
site	NULL
,	NULL
GASd	NULL
(	NULL
TTCTAGGA	NULL
A	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
in	NULL
vitro	NULL
StatSa	NULL
and	NULL
StatSb	NULL
proteins	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
IL-2	NULL
and	NULL
is	NULL
occupied	NULL
in	NULL
the	NULL
chromatin	NULL
of	NULL
IL-2-stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
GASd	NULL
is	NULL
the	NULL
first	NULL
IL-2-responsive	NULL
enhancer/promoter	NULL
element	NULL
characterized	NULL
within	NULL
its	NULL
physiological	NULL
context	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
.	NULL

Nucleotide	NULL
substitutions	NULL
disrupting	NULL
the	NULL
GAS	NULL
consensus	NULL
in	NULL
the	NULL
GASd/	NULL
EBSd	NULL
site	NULL
abolish	NULL
the	NULL
IL-2-induced	NULL
enhancer	NULL
activity	NULL
of	NULL
PPRIII	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
effects	NULL
of	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
mouse	NULL
IL-2rE	NULL
(	NULL
65	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
genomic	NULL
footprint	NULL
analysis	NULL
demonstrated	NULL
that	NULL
occupation	NULL
of	NULL
the	NULL
GASd/EBSd	NULL
site	NULL
was	NULL
induced	NULL
in	NULL
Kit225	NULL
cells	NULL
by	NULL
IL-2	NULL
and	NULL
in	NULL
human	NULL
primary	NULL
T	NULL
lymphocytes	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
CD2	NULL
and	NULL
CD28	NULL
antibodies	NULL
.	NULL

The	NULL
latter	NULL
stimulation	NULL
mimics	NULL
an-tigen-mediated	NULL
activation	NULL
and	NULL
triggers	NULL
potent	NULL
IL-2-dependent	NULL
proliferation	NULL
(	NULL
49	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
with	NULL
anti-CD2	NULL
and	NULL
-CD28	NULL
antibodies	NULL
induces	NULL
a	NULL
nearly	NULL
immediate	NULL
occupancy	NULL
of	NULL
the	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
contrasts	NULL
with	NULL
the	NULL
delayed	NULL
modification	NULL
of	NULL
the	NULL
distal	NULL
GASd/EBSd	NULL
element	NULL
(	NULL
de-tectable	NULL
only	NULL
after	NULL
18	NULL
to	NULL
24	NULL
h	NULL
of	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
lend	NULL
further	NULL
support	NULL
to	NULL
a	NULL
previously	NULL
proposed	NULL
two-stage	NULL
model	NULL
of	NULL
the	NULL
stimulation	NULL
of	NULL
IL-2Ra	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
65	NULL
)	NULL
,	NULL
according	NULL
to	NULL
which	NULL
antigen	NULL
induces	NULL
a	NULL
first	NULL
wave	NULL
of	NULL
transcription	NULL
via	NULL
promoter	NULL
proximal	NULL
elements	NULL
while	NULL
IL-2	NULL
is	NULL
responsible	NULL
for	NULL
a	NULL
secondary	NULL
amplification	NULL
mediated	NULL
by	NULL
the	NULL
IL-2rE	NULL
described	NULL
here	NULL
for	NULL
the	NULL
human	NULL
gene	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
IL-2-inducible	NULL
enhancer	NULL
activity	NULL
of	NULL
PRRIII	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
promoter	NULL
proximal	NULL
elements	NULL
mediating	NULL
antigen-triggered	NULL
transcription	NULL
.	NULL

The	NULL
same	NULL
is	NULL
true	NULL
for	NULL
the	NULL
mouse	NULL
IL-2rE	NULL
(	NULL
65	NULL
)	NULL
.	NULL

The	NULL
human	NULL
IL-2Ra	NULL
«	NULL
GASd	NULL
element	NULL
overlaps	NULL
with	NULL
an	NULL
ETS	NULL
binding	NULL
site	NULL
(	NULL
EBS	NULL
)	NULL
and	NULL
is	NULL
identical	NULL
with	NULL
the	NULL
GAS	NULL
site	NULL
of	NULL
the	NULL
bovine	NULL
B-casein	NULL
promoter	NULL
.	NULL

This	NULL
site	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
form	NULL
a	NULL
single	NULL
inducible	NULL
complex	NULL
identified	NULL
as	NULL
MGF/StatSa	NULL
with	NULL
extracts	NULL
from	NULL
different	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
stimulated	NULL
with	NULL
thrombopoietin	NULL
,	NULL
prolactin	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
or	NULL
granulo-	NULL
6836	NULL
LECINE	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
KIT225	NULL
CELLS	NULL
B	NULL
coding	NULL
strand	NULL
KIT225	NULL
CELLS	NULL
kel	NULL
ke	NULL
]	NULL
non-coding	NULL
strand	NULL
$	NULL
-	NULL
N	NULL
a	NULL
®	NULL
-4150	NULL
©	NULL
o	NULL
4	NULL
J	NULL
8	NULL
3	NULL
T	NULL
2	NULL
Fo	NULL
T	NULL
Z	NULL
o	NULL
maas	NULL
E	NULL
Y	NULL
ou	NULL
2	NULL
T	NULL
c	NULL
©	NULL
2	NULL
1	NULL
C	NULL
T	NULL
~4206	NULL
-	NULL
*~	NULL
«	NULL
omen	NULL
T	NULL
2	NULL
+	NULL
T	NULL
Z	NULL
f	NULL
;	NULL
GATA	NULL
amas	NULL
wens	NULL
g	NULL
GASd	NULL
-4141	NULL
wae	NULL
-	NULL
Amma	NULL
g	NULL
T	NULL
c	NULL
Too	NULL
tien	NULL
A	NULL
A	NULL
GASp	NULL
suse	NULL
c	NULL
|	NULL
|	NULL
EBSd	NULL
A	NULL
A	NULL
-4159	NULL
-	NULL
®*	NULL
«	NULL
=	NULL
to	NULL
wee	NULL
|	NULL
o	NULL
LL	NULL
cares	NULL
A	NULL
-4176	NULL
-	NULL
<	NULL
1	NULL
e	NULL
Susa	NULL
cuties	NULL
|	NULL
o-	NULL
l	NULL
-4172	NULL
-	NULL
wus	NULL
w	NULL
»	NULL
..	NULL
€	NULL
00	NULL
a	NULL
|	NULL
e	NULL
g-	NULL
-4169	NULL
[	NULL
--	NULL
-4170	NULL
lng	NULL
_/A_	NULL
C	NULL
T	NULL
-4179	NULL
-	NULL
g	NULL
<	NULL
%	NULL
z	NULL
EBSd	NULL
®	NULL
-4182	NULL
-	NULL
<	NULL
4	NULL
c	NULL
GASp/GATA	NULL
1	NULL
ase	NULL
G	NULL
GASd	NULL
A	NULL
A	NULL
seen	NULL
G	NULL
-4143	NULL
_	NULL
]	NULL
i	NULL
-4184	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1°	NULL
2	NULL
3	NULL
-	NULL
4	NULL
C	NULL
D	NULL
KIT225	NULL
CELLS	NULL
EIMEAOCYTE	NULL
P	NULL
coding	NULL
strand	NULL
coding	NULL
strand	NULL
+IL-2	NULL
cares	NULL
CD2	NULL
+	NULL
CD28	NULL
2	NULL
9	NULL
y	NULL
x	NULL
E	NULL
a	NULL
2	NULL
<	NULL
15	NULL
so	NULL
60	NULL
iso	NULL
=	NULL
£	NULL
#	NULL
-	NULL
24h	NULL
48h	NULL
72h	NULL
96h	NULL
-4199	NULL
-	NULL
rex	NULL
T	NULL
ro-pais	NULL
C|	NULL
GASd	NULL
-	NULL
-4232-	NULL
.	NULL

i	NULL
-	NULL
weer	NULL
:	NULL
,	NULL
T	NULL
B	NULL
HE	NULL
*	NULL
mus	NULL
-	NULL
zoms	NULL
**	NULL
A	NULL
fe-	NULL
C	NULL
were	NULL
is	NULL
_	NULL
ﬂ	NULL
EBSd	NULL
s	NULL
-	NULL
z	NULL
7	NULL
4183	NULL
-4176	NULL
-	NULL
A	NULL
Shak	NULL
po-	NULL
g	NULL
-4172	NULL
-	NULL
-	NULL
...	NULL
.._	NULL
‘	NULL
__'__-	NULL
:	NULL
]	NULL
o	NULL
‘	NULL
g	NULL
,	NULL
.=	NULL
“	NULL
f	NULL
A	NULL
pared	NULL
m	NULL
c|	NULL
casa	NULL
x	NULL
-4170	NULL
-	NULL
-	NULL
-	NULL
.	NULL

g	NULL
=	NULL
A	NULL
uze	NULL
i	NULL
EBSd	NULL
-	NULL
``	NULL
*	NULL
a	NULL
,	NULL
.	NULL

Bike	NULL
-	NULL
san	NULL
=	NULL
sous	NULL
o	NULL
<	NULL
4	NULL
a	NULL
>	NULL
lGASprATA	NULL
~4176	NULL
-|	NULL
|	NULL
pees	NULL
a	NULL
me	NULL
Te	NULL
|	NULL
<	NULL
©	NULL
Ca	NULL
-4172	NULL
-|	NULL
-	NULL
.	NULL

A	NULL
aA	NULL
a	NULL
%	NULL
*	NULL
*	NULL
%	NULL
ma	NULL
me	NULL
mes	NULL
to	NULL
<	NULL
8	NULL
[	NULL
~~~	NULL
-4143	NULL
-	NULL
we	NULL
R	NULL
1	NULL
o	NULL
2	NULL
og	NULL
400500	NULL
60	NULL
7	NULL
r	NULL
``	NULL
``	NULL
``	NULL
1	NULL
lGASp/GATA	NULL
as	NULL
wa	NULL
wz	NULL
ses~=	NULL
m	NULL
se	NULL
e	NULL
w	NULL
wane	NULL
fne	NULL
d	NULL
-	NULL
4132	NULL
-	NULL
]	NULL
wth	NULL
«	NULL
a	NULL
.	NULL

s	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
Jak-Stat	NULL
ACTIVATION	NULL
OF	NULL
IL-2Re	NULL
«	NULL
GENE	NULL
6837	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
IL-2rE	NULL
within	NULL
the	NULL
human	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
DMS/LM-PCR	NULL
was	NULL
performed	NULL
with	NULL
in	NULL
vitro	NULL
methylated	NULL
DNA	NULL
(	NULL
lane	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
DNA	NULL
from	NULL
Kit225	NULL
cells	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
IL-2	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
IL-2-starved	NULL
for	NULL
48	NULL
h	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Coding	NULL
strand	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Noncoding	NULL
strand	NULL
.	NULL

The	NULL
G-ladder	NULL
shown	NULL
in	NULL
lane	NULL
4	NULL
is	NULL
a	NULL
duplicate	NULL
of	NULL
lane	NULL
1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Time	NULL
course	NULL
of	NULL
the	NULL
appearance	NULL
of	NULL
protection	NULL
of	NULL
the	NULL
G	NULL
residue	NULL
at	NULL
position	NULL
-4176	NULL
in	NULL
the	NULL
coding	NULL
strand	NULL
.	NULL

Kit225	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
starved	NULL
for	NULL
IL-2	NULL
for	NULL
48	NULL
h	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
and	NULL
used	NULL
for	NULL
in	NULL
vivo	NULL
footprinting	NULL
.	NULL

Lane	NULL
1	NULL
:	NULL
in	NULL
vitro	NULL
methylated	NULL
DNA	NULL
.	NULL

(	NULL
D	NULL
)	NULL
DMS/LM-PCR	NULL
analysis	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
PRII	NULL
enhancer	NULL
in	NULL
chromatin	NULL
of	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
G	NULL
ladder	NULL
from	NULL
naked	NULL
DNA	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
in	NULL
vivo	NULL
methylated	NULL
DNA	NULL
from	NULL
unstimulated	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
anti-CD2	NULL
and	NULL
-CD28	NULL
antibodies	NULL
for	NULL
the	NULL
indicated	NULL
periods	NULL
.	NULL

The	NULL
autoradiograms	NULL
presented	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

To	NULL
account	NULL
for	NULL
the	NULL
random	NULL
variation	NULL
of	NULL
counts	NULL
per	NULL
residue	NULL
,	NULL
the	NULL
relative	NULL
intensities	NULL
of	NULL
the	NULL
bands	NULL
were	NULL
compared	NULL
by	NULL
densitometric	NULL
analysis	NULL
using	NULL
a	NULL
Biolmage	NULL
analyzer	NULL
.	NULL

Filled	NULL
arrowheads	NULL
on	NULL
the	NULL
right	NULL
side	NULL
of	NULL
the	NULL
panels	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
an	NULL
invariant	NULL
G	NULL
residue	NULL
at	NULL
position	NULL
-4172	NULL
,	NULL
and	NULL
the	NULL
open	NULL
arrowheads	NULL
mark	NULL
the	NULL
position	NULL
of	NULL
the	NULL
protected	NULL
G	NULL
residue	NULL
-4176	NULL
within	NULL
the	NULL
GASd/EBSd	NULL
element	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
.	NULL

On	NULL
the	NULL
right	NULL
side	NULL
of	NULL
panel	NULL
B	NULL
,	NULL
the	NULL
filled	NULL
arrowheads	NULL
correspond	NULL
to	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
constitutively	NULL
protected	NULL
G	NULL
residues	NULL
-4179	NULL
and	NULL
-4182	NULL
within	NULL
the	NULL
GASd/EBSd	NULL
site	NULL
,	NULL
and	NULL
-4159	NULL
within	NULL
the	NULL
GASp/GATA	NULL
site	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
.	NULL

cyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
17	NULL
,	NULL
50	NULL
,	NULL
73	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
that	NULL
extracts	NULL
from	NULL
T	NULL
lymphocytes	NULL
form	NULL
one	NULL
constitutive	NULL
and	NULL
two	NULL
IL-2-inducible	NULL
complexes	NULL
with	NULL
a	NULL
GASd/	NULL
EBSd	NULL
probe	NULL
.	NULL

The	NULL
constitutive	NULL
complex	NULL
contains	NULL
the	NULL
lymphocyte-specific	NULL
Ets	NULL
family	NULL
member	NULL
,	NULL
Elf-1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
some	NULL
Ets-1	NULL
and/or	NULL
2	NULL
and	NULL
Fli-1	NULL
,	NULL
whereas	NULL
the	NULL
IL-2-inducible	NULL
complexes	NULL
from	NULL
normal	NULL
IL-2-stimulated	NULL
T	NULL
cells	NULL
contain	NULL
StatSa	NULL
and	NULL
Stat5b	NULL
proteins	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
EBSd	NULL
consensus	NULL
leads	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
basal	NULL
but	NULL
not	NULL
in	NULL
IL-2-induced	NULL
PPRIII	NULL
enhancer	NULL
activity	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
EBSd	NULL
may	NULL
bind	NULL
a	NULL
protein	NULL
that	NULL
has	NULL
a	NULL
negative	NULL
effect	NULL
on	NULL
enhancer	NULL
activity	NULL
and	NULL
that	NULL
Stat5	NULL
may	NULL
act	NULL
,	NULL
in	NULL
part	NULL
,	NULL
by	NULL
competing	NULL
with	NULL
this	NULL
negative	NULL
regulator	NULL
.	NULL

In	NULL
this	NULL
connection	NULL
it	NULL
is	NULL
interesting	NULL
that	NULL
Ets-1	NULL
can	NULL
act	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
constitutive	NULL
in	NULL
vivo	NULL
protection	NULL
of	NULL
nucleotides	NULL
in	NULL
the	NULL
GASd/EBSd	NULL
site	NULL
in	NULL
chromatin	NULL
of	NULL
both	NULL
IL-2-starved	NULL
Kit225	NULL
or	NULL
primary	NULL
resting	NULL
T	NULL
cells	NULL
is	NULL
consistent	NULL
with	NULL
an	NULL
occupation	NULL
of	NULL
this	NULL
site	NULL
by	NULL
a	NULL
negative	NULL
regulator	NULL
.	NULL

Elf-1	NULL
,	NULL
the	NULL
protein	NULL
that	NULL
clearly	NULL
was	NULL
identified	NULL
in	NULL
the	NULL
constitutive	NULL
complex	NULL
formed	NULL
with	NULL
GASd/EBSd	NULL
probe	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
A	NULL
GAZd/EREd	NULL
TTTCTZTCTAGGAAGTA	NULL
GASd	NULL
intact	NULL
AGTA	NULL
TTTCGGC	NULL
ER3d	NULL
mutant	NULL
TIZCITCTCCGAAGTA	NULL
B	NULL
pTK4250	NULL
mEBSq	NULL
(	NULL
m	NULL
+11-2	NULL
:	NULL
D	NULL
~IL-2	NULL
pTK4	NULL
!	NULL

280	NULL
mGaASd	NULL
pThwzsd	NULL
pTK4	NULL
CAT	NULL
(	NULL
pg/ml	NULL
)	NULL
regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
T-cell	NULL
specific	NULL
genes	NULL
including	NULL
IL-2	NULL
and	NULL
IL-2R	NULL
«	NULL
(	NULL
26	NULL
,	NULL
70	NULL
)	NULL
,	NULL
but	NULL
it	NULL
has	NULL
not	NULL
been	NULL
described	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
.	NULL

However	NULL
,	NULL
the	NULL
experiments	NULL
showing	NULL
that	NULL
cotransfection	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
Elf-1	NULL
expression	NULL
vector	NULL
can	NULL
abolish	NULL
the	NULL
Stat5-dependent	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
the	NULL
human	NULL
IL-2rE	NULL
TK	NULL
CAT	NULL
reporter	NULL
gene	NULL
support	NULL
the	NULL
model	NULL
according	NULL
to	NULL
which	NULL
Elf-1	NULL
is	NULL
required	NULL
to	NULL
repress	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
in	NULL
nonac-tivated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Since	NULL
neither	NULL
of	NULL
the	NULL
two	NULL
anti-Elf-1	NULL
sera	NULL
,	NULL
nor	NULL
any	NULL
of	NULL
the	NULL
tested	NULL
Ets	NULL
antisera	NULL
,	NULL
completely	NULL
abrogated	NULL
or	NULL
supershifted	NULL
the	NULL
constitutive	NULL
GASd/EBSd-specific	NULL
complex	NULL
,	NULL
it	NULL
is	NULL
very	NULL
possible	NULL
that	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
or	NULL
EBS	NULL
binding	NULL
proteins	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-Z2Ra	NULL
«	NULL
expression	NULL
.	NULL

The	NULL
competition	NULL
experiments	NULL
show	NULL
that	NULL
the	NULL
affinity	NULL
of	NULL
the	NULL
EBSd	NULL
motif	NULL
for	NULL
the	NULL
constitutive	NULL
EMSA	NULL
complexes	NULL
is	NULL
considerably	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
Ets	NULL
proteins	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
EBSd	NULL
may	NULL
provide	NULL
yet	NULL
another	NULL
example	NULL
of	NULL
a	NULL
weak	NULL
Elf-1	NULL
binding	NULL
site	NULL
that	NULL
is	NULL
important	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
lymphocyte-specific	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
.	NULL

C	NULL
160	NULL
140	NULL
>	NULL
OA4L2	NULL
©	NULL
+1L2	NULL
120	NULL
€	NULL
10	NULL
Eo	NULL
soo	NULL
<	NULL
el	NULL
60	NULL
40	NULL
20	NULL
a	NULL
Reporter	NULL
[	NULL
pTKq	NULL
+	NULL
+	NULL
+	NULL
-	NULL
-	NULL
w	NULL
«	NULL
-L	NULL
prkaz2so	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Effector	NULL
|	NULL
Stats	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
a	NULL
L	NULL
eig-1	NULL
-	NULL
-	NULL
2.5	NULL
-	NULL
-	NULL
0.5	NULL
1	NULL
2.5	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
IL-2R	NULL
«	NULL
GASd/EBSd	NULL
motif	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nucleotide	NULL
substitutions	NULL
introduced	NULL
into	NULL
the	NULL
pTK4/250.5	NULL
'	NULL
construct	NULL
containing	NULL
the	NULL
human	NULL
IL-2rE	NULL
(	NULL
PRIII	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
overlapping	NULL
Stat	NULL
and	NULL
Ets	NULL
transcription	NULL
factor	NULL
consensus	NULL
sites	NULL
are	NULL
underlined	NULL
.	NULL

Substituted	NULL
nucleotides	NULL
are	NULL
in	NULL
boldface	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
normal	NULL
and	NULL
mutated	NULL
enhancer	NULL
constructs	NULL
in	NULL
the	NULL
Kit225	NULL
T-cell	NULL
line	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
IL-2	NULL
.	NULL

Transfections	NULL
were	NULL
analyzed	NULL
and	NULL
controlled	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
are	NULL
means	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
determinations	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
represent	NULL
standard	NULL
deviations	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Elf-1	NULL
can	NULL
serve	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
Stat5-mediated	NULL
activation	NULL
of	NULL
IL-2Ra	NULL
gene	NULL
transcription	NULL
.	NULL

Kit225	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
wild-type	NULL
pTK4/250.5	NULL
'	NULL
CAT	NULL
plasmid	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
and	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
StatSb	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
and	NULL
Elf-1	NULL
(	NULL
0.5	NULL
to	NULL
2.5	NULL
ug	NULL
)	NULL
.	NULL

The	NULL
data	NULL
are	NULL
given	NULL
as	NULL
means	NULL
and	NULL
standard	NULL
deviations	NULL
of	NULL
at	NULL
least	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

6838	NULL
LECINE	NULL
ET	NULL
AL	NULL
.	NULL

Ets	NULL
proteins	NULL
appear	NULL
to	NULL
control	NULL
transcription	NULL
by	NULL
associating	NULL
with	NULL
other	NULL
regulators	NULL
of	NULL
gene	NULL
expression	NULL
(	NULL
3	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
20	NULL
,	NULL
26	NULL
,	NULL
75	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
regulation	NULL
through	NULL
the	NULL
GASd/EBSd	NULL
element	NULL
may	NULL
depend	NULL
on	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
IL-2-induced	NULL
Stat5	NULL
and	NULL
the	NULL
Ets	NULL
proteins	NULL
binding	NULL
to	NULL
this	NULL
element	NULL
.	NULL

Although	NULL
we	NULL
so	NULL
far	NULL
have	NULL
failed	NULL
to	NULL
find	NULL
any	NULL
evidence	NULL
for	NULL
such	NULL
an	NULL
interac-tion	NULL
,	NULL
this	NULL
possibility	NULL
needs	NULL
to	NULL
be	NULL
explored	NULL
further	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
mouse	NULL
homolog	NULL
of	NULL
the	NULL
human	NULL
GASd/EBSd	NULL
site	NULL
does	NULL
not	NULL
contain	NULL
an	NULL
EBS	NULL
consensus	NULL
motif	NULL
.	NULL

This	NULL
may	NULL
be	NULL
a	NULL
reflection	NULL
of	NULL
differences	NULL
between	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
human	NULL
IL-2R	NULL
«	NULL
gene	NULL
.	NULL

A	NULL
discrepancy	NULL
between	NULL
these	NULL
species	NULL
has	NULL
already	NULL
been	NULL
observed	NULL
for	NULL
the	NULL
cis-regulatory	NULL
elements	NULL
in	NULL
promoter	NULL
proximal	NULL
region	NULL
.	NULL

Cooperative	NULL
interaction	NULL
between	NULL
NF-kB	NULL
and	NULL
SRF	NULL
,	NULL
binding	NULL
to	NULL
adjacent	NULL
sites	NULL
,	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
IL-Z2R	NULL
«	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
anti-CD2	NULL
plus	NULL
anti-CD28	NULL
(	NULL
1	NULL
,	NULL
33	NULL
,	NULL
52	NULL
)	NULL
,	NULL
but	NULL
the	NULL
mouse	NULL
gene	NULL
does	NULL
not	NULL
contain	NULL
an	NULL
SRE	NULL
consensus	NULL
motif	NULL
in	NULL
or	NULL
near	NULL
the	NULL
xB	NULL
site	NULL
conserved	NULL
in	NULL
both	NULL
species	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Alternatively	NULL
the	NULL
difference	NULL
between	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
GASd	NULL
sites	NULL
may	NULL
indicate	NULL
that	NULL
the	NULL
protein	NULL
that	NULL
mediates	NULL
the	NULL
function	NULL
of	NULL
the	NULL
human	NULL
EBSd	NULL
site	NULL
is	NULL
different	NULL
from	NULL
the	NULL
known	NULL
ETS	NULL
family	NULL
factors	NULL
.	NULL

Regardless	NULL
of	NULL
possible	NULL
species	NULL
differences	NULL
,	NULL
the	NULL
work	NULL
described	NULL
here	NULL
substantially	NULL
extends	NULL
previous	NULL
studies	NULL
indicating	NULL
that	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
gene	NULL
in	NULL
both	NULL
species	NULL
depends	NULL
on	NULL
temporally	NULL
and	NULL
spatially	NULL
coordinated	NULL
interactions	NULL
between	NULL
multiple	NULL
regulatory	NULL
proteins	NULL
.	NULL

These	NULL
interactions	NULL
serve	NULL
to	NULL
integrate	NULL
the	NULL
signals	NULL
from	NULL
the	NULL
various	NULL
membrane	NULL
receptors	NULL
that	NULL
control	NULL
the	NULL
efficient	NULL
and	NULL
accurate	NULL
expression	NULL
of	NULL
a	NULL
gene	NULL
that	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
immune	NULL
responses	NULL
(	NULL
1	NULL
,	NULL
26	NULL
,	NULL
65	NULL
)	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
deeply	NULL
indebted	NULL
to	NULL
H.	NULL
Dutartre	NULL
for	NULL
the	NULL
construction	NULL
of	NULL
the	NULL
human	NULL
GASd/EBSd	NULL
mutants	NULL
.	NULL

We	NULL
thank	NULL
J.	NULL
P.	NULL
Borg	NULL
,	NULL
D.	NULL
Cantrell	NULL
,	NULL
Y.	NULL
Collette	NULL
,	NULL
B.	NULL
Kahn-Perlés	NULL
,	NULL
C.	NULL
Mawas	NULL
,	NULL
and	NULL
D.	NULL
Olive	NULL
for	NULL
stimulating	NULL
advice	NULL
.	NULL

The	NULL
recombinant	NULL
phage	NULL
A39	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
T.	NULL
Honjo	NULL
.	NULL

Specific	NULL
antisera	NULL
and	NULL
constructs	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
F.	NULL
Gouilleux	NULL
,	NULL
B.	NULL
Groomer	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Leiden	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
and	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
the	NULL
Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
,	NULL
the	NULL
Comité	NULL
des	NULL
Bouches-du-Rhone	NULL
de	NULL
la	NULL
Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
,	NULL
and	NULL
the	NULL
European	NULL
Community	NULL
(	NULL
Biomed-1	NULL
CT	NULL
93-1426	NULL
and	NULL
CHRX	NULL
CT	NULL
94-0537	NULL
)	NULL
.	NULL

P.	NULL
Lécine	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
and	NULL
P.	NULL
Rameil	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Ministére	NULL
de	NULL
l'Enseignement	NULL
Supérieur	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Algarte	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Lecine	NULL
,	NULL
R.	NULL
Costello	NULL
,	NULL
A.	NULL
Plet	NULL
,	NULL
D.	NULL
Olive	NULL
,	NULL
and	NULL
J.	NULL
Imbert	NULL
.	NULL

1995	NULL
.	NULL

In	NULL
vivo	NULL
regulation	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
gene	NULL
transcription	NULL
by	NULL
the	NULL
coordinated	NULL
binding	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
factors	NULL
in	NULL
human	NULL
primary	NULL
T-cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

214:5060-5072	NULL
.	NULL

2	NULL
.	NULL

Bailly	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
J.	NULL
Zucman	NULL
,	NULL
F.	NULL
Cormier	NULL
,	NULL
O.	NULL
Delattre	NULL
,	NULL
M.	NULL
Roussel	NULL
,	NULL
G.	NULL
Thomas	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1994	NULL
.	NULL

DNA-binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
EWS-FLI-1	NULL
fusion	NULL
protein	NULL
resulting	NULL
from	NULL
the	NULL
t	NULL
(	NULL
11	NULL
;	NULL
22	NULL
)	NULL
translocation	NULL
in	NULL
Ewing	NULL
sarcoma	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

14:3230-3241	NULL
.	NULL

3	NULL
.	NULL

Bassuk	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
direct	NULL
physical	NULL
association	NULL
between	NULL
ETS	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
3:223-237	NULL
.	NULL

4	NULL
.	NULL

Beadling	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
Guschin	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
A.	NULL
Ziemiecki	NULL
,	NULL
J.	NULL
N.	NULL
Ihle	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
JAK	NULL
kinases	NULL
and	NULL
STAT	NULL
proteins	NULL
by	NULL
interleukin	NULL
2	NULL
and	NULL
interferon	NULL
alpha	NULL
,	NULL
but	NULL
not	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
,	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5605-5615	NULL
.	NULL

5	NULL
.	NULL

Beadling	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Ng	NULL
,	NULL
J.	NULL
W.	NULL
Babbage	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-2	NULL
activation	NULL
of	NULL
STATS	NULL
requires	NULL
the	NULL
convergent	NULL
action	NULL
of	NULL
tyrosine	NULL
kinases	NULL
and	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
pathway	NULL
distinct	NULL
from	NULL
the	NULL
Raf1/ERK2	NULL
MAP	NULL
kinase	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1902-1913	NULL
.	NULL

6	NULL
.	NULL

Brunn	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
E.	NULL
L.	NULL
Falls	NULL
,	NULL
A.	NULL
E.	NULL
Nilson	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Abraham	NULL
.	NULL

1995	NULL
.	NULL

Protein-tyrosine	NULL
kinase-dependent	NULL
activation	NULL
of	NULL
STAT	NULL
transcription	NULL
factors	NULL
in	NULL
inter-leukin-2-	NULL
or	NULL
interleukin-4-stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
11628-11635	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

7	NULL
.	NULL

Cosman	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
P.	NULL
Cerretti	NULL
,	NULL
A.	NULL
Larsen	NULL
,	NULL
L.	NULL
Park	NULL
,	NULL
C.	NULL
March	NULL
,	NULL
S.	NULL
Dower	NULL
,	NULL
S.	NULL
Gillis	NULL
,	NULL
and	NULL
D.	NULL
Urdal	NULL
.	NULL

1984	NULL
.	NULL

Cloning	NULL
,	NULL
sequence	NULL
and	NULL
expression	NULL
of	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
312:768-771	NULL
.	NULL

8	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
chain	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
nonfunctional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
.	NULL

Cell	NULL
49:47-56	NULL
.	NULL

9	NULL
.	NULL

Dalton	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
SAP-1	NULL
,	NULL
a	NULL
protein	NULL
recruited	NULL
by	NULL
serum	NULL
response	NULL
factor	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Cell	NULL
68:597-612	NULL
.	NULL

10	NULL
.	NULL

Damen	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
H.	NULL
Wakao	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
J.	NULL
Krosl	NULL
,	NULL
R.	NULL
K.	NULL
Humphries	NULL
,	NULL
R.	NULL
L.	NULL
Cutler	NULL
,	NULL
and	NULL
G.	NULL
Krystal	NULL
.	NULL

1995	NULL
.	NULL

Tyrosine	NULL
343	NULL
in	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
positively	NULL
regulates	NULL
erythropoictin-induced	NULL
cell	NULL
proliferation	NULL
and	NULL
Stats	NULL
acti-vation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:5557-5568	NULL
.	NULL

11	NULL
.	NULL

Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
,	NULL
C.	NULL
Drogula	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
T.	NULL
A.	NULL
Waldmann	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1985	NULL
.	NULL

Interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
augments	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:4230-4234	NULL
.	NULL

12	NULL
.	NULL

Dudek	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
V.	NULL
Tantravahi	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
E.	NULL
S.	NULL
P.	NULL
Reddy	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Reddy	NULL
.	NULL

1992	NULL
.	NULL

Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
cooperate	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
mim-1	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1291-1295	NULL
.	NULL

13	NULL
.	NULL

Firmbach-Kraft	NULL
,	NULL
L	NULL
,	NULL
M.	NULL
Byers	NULL
,	NULL
T.	NULL
Shows	NULL
,	NULL
R.	NULL
Dalla-Favera	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Krolewski	NULL
.	NULL

1990.	NULL
tyk2	NULL
,	NULL
prototype	NULL
of	NULL
a	NULL
novel	NULL
class	NULL
of	NULL
non-receptor	NULL
tyrosine	NULL
kinase	NULL
genes	NULL
.	NULL

Oncogene	NULL
5:1329-1336	NULL
.	NULL

14	NULL
.	NULL

Foecking	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
H.	NULL
Hofstetter	NULL
.	NULL

1986	NULL
.	NULL

Powerful	NULL
and	NULL
versatile	NULL
enhancer-promoter	NULL
unit	NULL
for	NULL
mammalian	NULL
expression	NULL
unit	NULL
.	NULL

Gene	NULL
45:101-105	NULL
.	NULL

15	NULL
.	NULL

Frank	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
M.	NULL
J.	NULL
Robertson	NULL
,	NULL
A.	NULL
Bonni	NULL
,	NULL
J.	NULL
Ritz	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
2	NULL
signaling	NULL
involves	NULL
the	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7779-7783	NULL
.	NULL

16	NULL
.	NULL

Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
M.	NULL
Abdich	NULL
,	NULL
J.	NULL
Eisenman	NULL
,	NULL
K.	NULL
Shanebeck	NULL
,	NULL
K.	NULL
Grabstein	NULL
,	NULL
S.	NULL
Kumaki	NULL
,	NULL
A.	NULL
Namen	NULL
,	NULL
L.	NULL
S.	NULL
Park	NULL
,	NULL
D.	NULL
Cosman	NULL
,	NULL
and	NULL
D.	NULL
Anderson	NULL
.	NULL

1994	NULL
.	NULL

Utilization	NULL
of	NULL
the	NULL
beta	NULL
and	NULL
gamma	NULL
chains	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
by	NULL
the	NULL
novel	NULL
cytokine	NULL
IL-15	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:2822-2830	NULL
.	NULL

16a.Gouilleux	NULL
,	NULL
F.	NULL
Personal	NULL
communication	NULL
.	NULL

17	NULL
.	NULL

Gouilleux	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Pallard	NULL
,	NULL
I.	NULL
Dusanter-Fourt	NULL
,	NULL
H.	NULL
Wakao	NULL
,	NULL
L.	NULL
A.	NULL
Haldosen	NULL
,	NULL
G.	NULL
Norstedt	NULL
,	NULL
D.	NULL
Levy	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1995	NULL
.	NULL

Prolactin	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
erythropoietin	NULL
and	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
induce	NULL
MGF-Stat5	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2005-2013	NULL
.	NULL

18	NULL
.	NULL

Hori	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Uchiyama	NULL
,	NULL
M.	NULL
Tsudo	NULL
,	NULL
H.	NULL
Umadome	NULL
,	NULL
H.	NULL
Ohno	NULL
,	NULL
S.	NULL
Fukuhara	NULL
,	NULL
K.	NULL
Kita	NULL
,	NULL
and	NULL
H.	NULL
Uchino	NULL
.	NULL

1987	NULL
.	NULL

Establishment	NULL
of	NULL
an	NULL
interleukin	NULL
2-dependent	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
T	NULL
cell	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
who	NULL
is	NULL
not	NULL
infected	NULL
with	NULL
human	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
virus	NULL
.	NULL

Blood	NULL
70:1069-1072	NULL
.	NULL

19	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
S.	NULL
C.	NULL
Wong	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
and	NULL
purification	NULL
of	NULL
human	NULL
Stat	NULL
proteins	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
interleukin-2	NULL
.	NULL

Immunity	NULL
2321-329	NULL
.	NULL

20	NULL
.	NULL

Howard	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maurer	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
composite	NULL
Ets/Pit-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
prolactin	NULL
gene	NULL
can	NULL
mediate	NULL
transcriptional	NULL
responses	NULL
to	NULL
multiple	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:20930-20936	NULL
.	NULL

21	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
1993	NULL
.	NULL

Signal	NULL
transduction	NULL
.	NULL

Cytokine	NULL
connections	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
366:114-116	NULL
.	NULL

22	NULL
.	NULL

Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
and	NULL
O.	NULL
Silvennoinen	NULL
.	NULL

1995	NULL
.	NULL

Signaling	NULL
through	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
receptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

13:369-398	NULL
.	NULL

23	NULL
.	NULL

Ishida	NULL
,	NULL
N.	NULL
,	NULL
H.	NULL
Kanamori	NULL
,	NULL
T.	NULL
Noma	NULL
,	NULL
T.	NULL
Nikaido	NULL
,	NULL
H.	NULL
Sabe	NULL
,	NULL
N.	NULL
Suzuki	NULL
,	NULL
A.	NULL
Shimizu	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1985	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13:7579-7589	NULL
.	NULL

24	NULL
.	NULL

Ivashkiv	NULL
,	NULL
L.	NULL
B	NULL
.	NULL

1995	NULL
.	NULL

Cytokines	NULL
and	NULL
STATs	NULL
:	NULL
how	NULL
can	NULL
signals	NULL
achieve	NULL
speci-ficity	NULL
?	NULL

Immunity	NULL
3:1-4	NULL
.	NULL

25	NULL
.	NULL

John	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Marais	NULL
,	NULL
R.	NULL
Child	NULL
,	NULL
Y	NULL
.	NULL

Light	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1996	NULL
.	NULL

Importance	NULL
of	NULL
low	NULL
affinity	NULL
Elf-1	NULL
sites	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
lymphoid-specific	NULL
inducible	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:743-750	NULL
.	NULL

26	NULL
.	NULL

John	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
B.	NULL
Reeves	NULL
,	NULL
J.-X	NULL
.	NULL

Lin	NULL
,	NULL
R.	NULL
Child	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
cell-type-specific	NULL
interleukin-2	NULL
receptor	NULL
-chain	NULL
gene	NULL
expression	NULL
:	NULL
potential	NULL
role	NULL
of	NULL
physical	NULL
interactions	NULL
between	NULL
Elf-1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
NF-xB	NULL
family	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
1786-1796	NULL
.	NULL

27	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
R.	NULL
A.	NULL
Kirken	NULL
,	NULL
Y.	NULL
Q.	NULL
Chen	NULL
,	NULL
T.	NULL
B.	NULL
Blake	NULL
,	NULL
K.	NULL
Shibuya	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1994	NULL
.	NULL

Phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
JAK-3	NULL
janus	NULL
kinase	NULL
in	NULL
response	NULL
to	NULL
interleukin-1	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
370:151-153	NULL
.	NULL

28	NULL
.	NULL

Kirken	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
H.	NULL
Rui	NULL
,	NULL
M.	NULL
G.	NULL
Malabarba	NULL
,	NULL
and	NULL
W.	NULL
L.	NULL
Farrar	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
interleukin-2	NULL
receptor-associated	NULL
tyrosine	NULL
kinase	NULL
p116	NULL
as	NULL
novel	NULL
Ieukocyte-specific	NULL
janus	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:19136-19141	NULL
.	NULL

29	NULL
.	NULL

Kirken	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
H.	NULL
Rui	NULL
,	NULL
M.	NULL
G.	NULL
Malabarba	NULL
,	NULL
O.	NULL
M.	NULL
Z.	NULL
Howard	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
W.	NULL
L.	NULL
Farrar	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
Jak3	NULL
,	NULL
but	NULL
not	NULL
Jak1	NULL
,	NULL
is	NULL
critical	NULL
for	NULL
IL-2	NULL
induced	NULL
proliferation	NULL
and	NULL
Stat5	NULL
recruitment	NULL
by	NULL
a	NULL
COOH-terminal	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
beta-chain	NULL
.	NULL

Cytokine	NULL
7:689-700	NULL
.	NULL

30	NULL
.	NULL

Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Engel	NULL
.	NULL

1993	NULL
.	NULL

DNA-binding	NULL
specificities	NULL
of	NULL
the	NULL
GATA	NULL
transcription	NULL
factor	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4011-4022	NULL
.	NULL

31	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
S.	NULL
Watanabe	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1993	NULL
.	NULL

Sharing	NULL
of	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
gamma	NULL
chain	NULL
between	NULL
receptors	NULL
for	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

Science	NULL
262:1874-1877	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
32	NULL
.	NULL

33	NULL
.	NULL

Krolewski	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
R.	NULL
Lee	NULL
,	NULL
R.	NULL
Eddy	NULL
,	NULL
T.	NULL
B	NULL
.	NULL

Shows	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
and	NULL
chromosomal	NULL
mapping	NULL
of	NULL
new	NULL
human	NULL
tyrosine	NULL
kinase	NULL
genes	NULL
.	NULL

Oncogene	NULL
5:277-282	NULL
.	NULL

Kuang	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
K.	NULL
D.	NULL
Novak	NULL
,	NULL
S.	NULL
M.	NULL
Kang	NULL
,	NULL
K.	NULL
Bruhn	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

Interaction	NULL
between	NULL
NF-kappa	NULL
B	NULL
and	NULL
serum	NULL
response	NULL
factor-binding	NULL
elements	NULL
activates	NULL
an	NULL
interleukin-2	NULL
receptor	NULL
alpha-chain	NULL
enhancer	NULL
specifically	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:2536-2545	NULL
.	NULL

33a.Lécine	NULL
,	NULL
P.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
receptor	NULL
;	NULL
structure	NULL
,	NULL
function	NULL
,	NULL
intra-cellular	NULL
messengers	NULL
and	NULL
molecular	NULL
regulation	NULL
,	NULL
p.	NULL
24-96	NULL
.	NULL

In	NULL
J.	NULL
Wawman	NULL
and	NULL
F.	NULL
Balkwill	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Interleukin-2	NULL
.	NULL

Blackwell	NULL
Scientific	NULL
Publications	NULL
Ltd	NULL
,	NULL
Ox-ford	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
J.	NULL
M.	NULL
Depper	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
S.	NULL
Rudikoff	NULL
,	NULL
J.	NULL
Pumbhrey	NULL
,	NULL
R.	NULL
J.	NULL
Robb	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
P.	NULL
B.	NULL
Svetlik	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
T.	NULL
A.	NULL
Waldmann	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1984	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
cDNAs	NULL
for	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
311:626-631	NULL
.	NULL

Lin	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
S.	NULL
L.	NULL
Cross	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
D.	NULL
G.	NULL
Roman	NULL
,	NULL
M.	NULL
B.	NULL
Toledano	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1990	NULL
.	NULL

Delineation	NULL
of	NULL
an	NULL
enhancerlike	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
alpha-chain	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:850-853	NULL
.	NULL

Lin	NULL
,	NULL
J.	NULL
X.	NULL
,	NULL
T.	NULL
S.	NULL
Migone	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Weatherbee	NULL
,	NULL
L.	NULL
Zhou	NULL
,	NULL
A.	NULL
Yamauchi	NULL
,	NULL
E.	NULL
T.	NULL
Bloom	NULL
,	NULL
J.	NULL
Mictz	NULL
,	NULL
S.	NULL
John	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motifs	NULL
and	NULL
common	NULL
Stat	NULL
proteins	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiotropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
IL-15	NULL
.	NULL

Immunity	NULL
2231-339	NULL
.	NULL

Liu	NULL
,	NULL
X.	NULL
,	NULL
G.	NULL
W.	NULL
Robinson	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
and	NULL
L.	NULL
Henninghausen	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
Stat5	NULL
and	NULL
an	NULL
additional	NULL
homologue	NULL
(	NULL
StatSb	NULL
)	NULL
involved	NULL
in	NULL
prolactin	NULL
signal	NULL
transduction	NULL
in	NULL
mouse	NULL
mammary	NULL
tissue	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:8831-8835	NULL
.	NULL

Matsuzawa	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Matsuda	NULL
,	NULL
Y.	NULL
Mizuno	NULL
,	NULL
and	NULL
K.	NULL
Kikuchi	NULL
.	NULL

1993	NULL
.	NULL

IL-2	NULL
induces	NULL
transient	NULL
and	NULL
specific	NULL
decrease	NULL
in	NULL
cytosolic	NULL
protein	NULL
phosphatase	NULL
PP1	NULL
activity	NULL
in	NULL
murine	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

195:989-996	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1980	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavages	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65:499-560	NULL
.	NULL

Miksicek	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Heber	NULL
,	NULL
W.	NULL
Schmid	NULL
,	NULL
U.	NULL
Danesch	NULL
,	NULL
G.	NULL
Posseckert	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
and	NULL
G.	NULL
Schiitz	NULL
.	NULL

1986	NULL
.	NULL

Glucocorticoid	NULL
responsiveness	NULL
of	NULL
the	NULL
transcriptional	NULL
enhancer	NULL
of	NULL
moloney	NULL
murine	NULL
sarcoma	NULL
virus	NULL
.	NULL

Cell	NULL
46:283-290	NULL
.	NULL

Minami	NULL
,	NULL
Y.	NULL
,	NULL
T.	NULL
Kono	NULL
,	NULL
T.	NULL
Miyazaki	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
IL-2	NULL
receptor	NULL
complex	NULL
:	NULL
its	NULL
structure	NULL
,	NULL
function	NULL
,	NULL
and	NULL
target	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:245-267	NULL
.	NULL

Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Kawahara	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
Y.	NULL
Nakagawa	NULL
,	NULL
Y.	NULL
Minami	NULL
,	NULL
Z.	NULL
J.	NULL
Lin	NULL
,	NULL
I.	NULL
Oishi	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
J.	NULL
N.	NULL
Ihle	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak3	NULL
by	NULL
selective	NULL
association	NULL
with	NULL
IL-2	NULL
receptor	NULL
subunits	NULL
.	NULL

Science	NULL
266:1045-1047	NULL
.	NULL

Mui	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
H.	NULL
Wakao	NULL
,	NULL
A.	NULL
M.	NULL
O'Farrell	NULL
,	NULL
N.	NULL
Harada	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1995	NULL
.	NULL

Interleukin-3	NULL
,	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
and	NULL
interleukin-5	NULL
transduce	NULL
signals	NULL
through	NULL
two	NULL
STATS5	NULL
homologs	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1166-1175	NULL
.	NULL

Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
M.	NULL
Russell	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

Mess	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
M.	NULL
Erdos	NULL
,	NULL
C.	NULL
Francois	NULL
,	NULL
Y.	NULL
Jacques	NULL
,	NULL
S.	NULL
Adelstein	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1994	NULL
.	NULL

Heterodimer-ization	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
beta-	NULL
gamma-chain	NULL
cytoplasmic	NULL
domains	NULL
is	NULL
required	NULL
for	NULL
signalling	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
369:330-333	NULL
.	NULL

Nelson	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
J.	NULL
D.	NULL
Lord	NULL
,	NULL
and	NULL
P.	NULL
D.	NULL
Greenberg	NULL
.	NULL

1994	NULL
.	NULL

Cytoplasmic	NULL
domains	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
beta	NULL
and	NULL
gamma	NULL
chains	NULL
mediate	NULL
the	NULL
signal	NULL
for	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
369:333-336	NULL
.	NULL

Nishi	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Ishida	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1988	NULL
.	NULL

Expression	NULL
of	NULL
functional	NULL
interleukin-2	NULL
receptors	NULL
in	NULL
human	NULL
light	NULL
chain/Tac	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
331:267-269	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
S.	NULL
M.	NULL
Russell	NULL
,	NULL
S.	NULL
F.	NULL
Ziegler	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
X.	NULL
Cao	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
gamma	NULL
chain	NULL
:	NULL
a	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
interleukin-7	NULL
receptor	NULL
.	NULL

Science	NULL
262:1877-1880	NULL
.	NULL

Olive	NULL
,	NULL
D.	NULL
,	NULL
F.	NULL
Pages	NULL
,	NULL
S.	NULL
Klasen	NULL
,	NULL
M.	NULL
Battifora	NULL
,	NULL
R.	NULL
Costello	NULL
,	NULL
J.	NULL
Nunes	NULL
,	NULL
A.	NULL
Trunch	NULL
,	NULL
M.	NULL
Ragueneau	NULL
,	NULL
Y.	NULL
Martin	NULL
,	NULL
J.	NULL
Imbert	NULL
,	NULL
F.	NULL
Birg	NULL
,	NULL
C.	NULL
Mawas	NULL
,	NULL
M.	NULL
Bagnasco	NULL
,	NULL
and	NULL
C.	NULL
Cerdan	NULL
.	NULL

1994	NULL
.	NULL

Stimulation	NULL
via	NULL
the	NULL
CD28	NULL
molecule	NULL
.	NULL

Regulated	NULL
of	NULL
signal-ling	NULL
,	NULL
cytokine	NULL
production	NULL
and	NULL
cytokine	NULL
receptor	NULL
expression	NULL
.	NULL

Fundam	NULL
.	NULL

Clin	NULL
.	NULL

Immunol	NULL
.	NULL

2185-197	NULL
.	NULL

Pallard	NULL
,	NULL
C.	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
L.	NULL
Benit	NULL
,	NULL
L.	NULL
Cocault	NULL
,	NULL
M.	NULL
Souyri	NULL
,	NULL
D.	NULL
Levy	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
S.	NULL
Gisselbrecht	NULL
,	NULL
and	NULL
I.	NULL
Dusanter-Fourt	NULL
.	NULL

1995	NULL
.	NULL

Thrombepoictin	NULL
activates	NULL
a	NULL
STATS5-like	NULL
factor	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2847-2856	NULL
.	NULL

Pazmany	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
P.	NULL
Murphy	NULL
,	NULL
S.	NULL
O.	NULL
Gollnick	NULL
,	NULL
S.	NULL
P.	NULL
Brooks	NULL
,	NULL
and	NULL
T.	NULL
B.	NULL
Tomasi	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
and	NULL
fos	NULL
and	NULL
jun	NULL
gene	NULL
family	NULL
expression	NULL
in	NULL
cells	NULL
exposed	NULL
to	NULL
a	NULL
single	NULL
electric	NULL
pulse	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

221:103-110	NULL
.	NULL

Pierce	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
C.	NULL
A.	NULL
Jamieson	NULL
,	NULL
J.	NULL
L.	NULL
Ross	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1995	NULL
.	NULL

Activation	NULL
of	NULL
IL-2	NULL
receptor	NULL
alpha-chain	NULL
gene	NULL
by	NULL
individual	NULL
members	NULL
of	NULL
the	NULL
rel	NULL
oncogene	NULL
family	NULL
in	NULL
association	NULL
with	NULL
serum	NULL
response	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:1972-1980	NULL
.	NULL

Pimentel-Muinos	NULL
,	NULL
F.	NULL
X.	NULL
,	NULL
M.	NULL
A.	NULL
Munoz-Fernandez	NULL
,	NULL
and	NULL
M.	NULL
Fresno	NULL
.	NULL

1994	NULL
.	NULL

Control	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
and	NULL
IL-2	NULL
receptor	NULL
expression	NULL
by	NULL
endog-enously	NULL
secreted	NULL
lymphokines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:5714-5722	NULL
.	NULL

Plaetinck	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
C.	NULL
Combe	NULL
,	NULL
P.	NULL
Corthesy	NULL
,	NULL
P.	NULL
Sperisen	NULL
,	NULL
H.	NULL
Kanamori	NULL
,	NULL
T.	NULL
Honjo	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1990	NULL
.	NULL

Control	NULL
of	NULL
IL-2	NULL
receptor-alpha	NULL
expression	NULL
by	NULL
IL-1	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
and	NULL
IL-2	NULL
.	NULL

Complex	NULL
regulation	NULL
via	NULL
elements	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:3340-3347	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

Jak-Stat	NULL
ACTIVATION	NULL
OF	NULL
IL-2Re	NULL
«	NULL
GENE	NULL
6839	NULL
Pognonec	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
E.	NULL
Boulukos	NULL
,	NULL
J.	NULL
C.	NULL
Gesquiere	NULL
,	NULL
D.	NULL
Stehelin	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1988	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
of	NULL
thymocytes	NULL
results	NULL
in	NULL
the	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
c-ets-1	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:977-983	NULL
.	NULL

Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
K.	NULL
Shimoda	NULL
,	NULL
W.	NULL
Thierfelder	NULL
,	NULL
C.	NULL
Fischer	NULL
,	NULL
A.	NULL
Kim	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
J.	NULL
L.	NULL
Cleveland	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thle	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
of	NULL
murine	NULL
Stat6	NULL
and	NULL
human	NULL
Stat6	NULL
,	NULL
Stat	NULL
proteins	NULL
that	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
IL-3	NULL
but	NULL
are	NULL
not	NULL
required	NULL
for	NULL
mitogenesis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3336-3343	NULL
.	NULL

Romano-Spica	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Georgiou	NULL
,	NULL
H.	NULL
Suzuki	NULL
,	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
N.	NULL
K.	NULL
Bhat	NULL
.	NULL

1995	NULL
.	NULL

Role	NULL
of	NULL
ETS1	NULL
in	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:2724-2732	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
M.	NULL
Berg	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
A.	NULL
S.	NULL
Goldman	NULL
,	NULL
F.	NULL
C.	NULL
Schmalstieg	NULL
,	NULL
J.	NULL
N.	NULL
Ihle	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
IL-2R	NULL
beta	NULL
and	NULL
gamma	NULL
(	NULL
c	NULL
)	NULL
chains	NULL
with	NULL
JAK1	NULL
and	NULL
JAK3-implications	NULL
for	NULL
XSCID	NULL
and	NULL
XCID	NULL
.	NULL

Science	NULL
266:1042-1045	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
N.	NULL
Harada	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
P.	NULL
Leland	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
M.	NULL
Friedman	NULL
,	NULL
C.	NULL
A.	NULL
Miyajima	NULL
,	NULL
R.	NULL
K.	NULL
Puri	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
gamma	NULL
chain	NULL
:	NULL
a	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
.	NULL

Science	NULL
262:1880-1882	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
1995	NULL
.	NULL

Transcriptional	NULL
response	NULL
to	NULL
polypeptide	NULL
ligands	NULL
:	NULL
the	NULL
Jak/Stat	NULL
pathway	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64:621-651	NULL
.	NULL

Seidel	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
L.	NULL
H.	NULL
Milocco	NULL
,	NULL
P.	NULL
Lamb	NULL
,	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
,	NULL
R.	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
J.	NULL
Rosen	NULL
.	NULL

1995	NULL
.	NULL

Spacing	NULL
of	NULL
palindromic	NULL
half	NULL
sites	NULL
as	NULL
a	NULL
determinant	NULL
of	NULL
selective	NULL
STAT	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:3041-3045	NULL
.	NULL

Shuai	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
M.	NULL
Horvath	NULL
,	NULL
L.	NULL
H.	NULL
Huang	NULL
,	NULL
S.	NULL
A.	NULL
Qureshi	NULL
,	NULL
D.	NULL
Cowburn	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Interferon	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Stat91	NULL
involves	NULL
dimerization	NULL
through	NULL
SH2-phosphotyrosyl	NULL
peptide	NULL
interactions	NULL
.	NULL

Cell	NULL
76:821-828	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

1988	NULL
.	NULL

Interleukin-2	NULL
:	NULL
inception	NULL
,	NULL
impact	NULL
,	NULL
and	NULL
implications	NULL
.	NULL

Science	NULL
240:1169-1176	NULL
.	NULL

Soldaini	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Pla	NULL
,	NULL
F.	NULL
Beermann	NULL
,	NULL
E.	NULL
Espel	NULL
,	NULL
P.	NULL
Corthesy	NULL
,	NULL
S.	NULL
Barange	NULL
,	NULL
G.	NULL
A.	NULL
Waanders	NULL
,	NULL
H.	NULL
R.	NULL
MacDonald	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1995	NULL
.	NULL

Mouse	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
gene	NULL
expression	NULL
.	NULL

Delimitation	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
in	NULL
transgenic	NULL
mice	NULL
and	NULL
by	NULL
mapping	NULL
of	NULL
DNAse-I	NULL
hypersensitive	NULL
sites	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:10733-10742	NULL
.	NULL

Sperisen	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
M.	NULL
Wang	NULL
,	NULL
E.	NULL
Soldaini	NULL
,	NULL
M.	NULL
Pla	NULL
,	NULL
C.	NULL
Rusterholz	NULL
,	NULL
P.	NULL
Bucher	NULL
,	NULL
P.	NULL
Corthesy	NULL
,	NULL
P.	NULL
Reichenbach	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1995	NULL
.	NULL

Mouse	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
gene	NULL
expression-interleukin-1	NULL
and	NULL
interleukin-2	NULL
control	NULL
transcription	NULL
via	NULL
distinct	NULL
cis-acting	NULL
elements	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:10743-10753	NULL
.	NULL

Suzuki	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Matsunami	NULL
,	NULL
H.	NULL
Kanamori	NULL
,	NULL
N.	NULL
Ishida	NULL
,	NULL
A.	NULL
Shimizu	NULL
,	NULL
Y.	NULL
Yaoita	NULL
,	NULL
T.	NULL
Nikaido	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
human	NULL
IL-2	NULL
receptor	NULL
gene	NULL
contains	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
that	NULL
functions	NULL
in	NULL
cultured	NULL
cells	NULL
and	NULL
cell-free	NULL
extracts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:5079-5086	NULL
.	NULL

Takeshita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Asao	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
S.	NULL
Kumaki	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Munakata	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
gamma	NULL
chain	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
.	NULL

Science	NULL
257:379-382	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Matsui	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
M.	NULL
Hatakeyama	NULL
,	NULL
N.	NULL
Kashima	NULL
,	NULL
A.	NULL
Fuse	NULL
,	NULL
J.	NULL
Hamuro	NULL
,	NULL
C.	NULL
Nishi-Takaoka	NULL
,	NULL
and	NULL
G.	NULL
Yamada	NULL
.	NULL

1986	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
interleukin-2	NULL
system	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

92:121-133	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Y.	NULL
Minami	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
IL-2/IL-2	NULL
receptor	NULL
system	NULL
:	NULL
a	NULL
current	NULL
overview	NULL
.	NULL

Cell	NULL
73:5-8	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
C.	NULL
Wang	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
B.	NULL
Bohjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992.	NULL
cis-acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
Ets-related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043-1053	NULL
.	NULL

Voss	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
T.	NULL
P.	NULL
Leary	NULL
,	NULL
P.	NULL
M.	NULL
Sondel	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Robb	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
interleukin	NULL
2	NULL
and	NULL
the	NULL
p64	NULL
interleukin	NULL
2	NULL
receptor	NULL
gamma	NULL
chain	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2428-2432	NULL
.	NULL

Wakao	NULL
,	NULL
H.	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
,	NULL
1994	NULL
.	NULL

Mammary	NULL
gland	NULL
factor	NULL
(	NULL
MGF	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
regulated	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
and	NULL
confers	NULL
the	NULL
prolactin	NULL
response	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:2182-2191	NULL
.	NULL

Wakao	NULL
,	NULL
H.	NULL
,	NULL
N.	NULL
Harada	NULL
,	NULL
T.	NULL
Kitamura	NULL
,	NULL
A.	NULL
L.	NULL
Mui	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
2	NULL
and	NULL
erythropoietin	NULL
activate	NULL
STAT5/MGF	NULL
via	NULL
distinct	NULL
pathways	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2527-2535	NULL
.	NULL

Waldmann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
IL-2/IL-2	NULL
receptor	NULL
system	NULL
:	NULL
a	NULL
target	NULL
for	NULL
rational	NULL
immune	NULL
intervention	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:264-270	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
W.	NULL
G.	NULL
Kaelin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
Elf-1	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
retinoblastmona	NULL
protein	NULL
.	NULL

Science	NULL
260:1330-1335	NULL
.	NULL

Wang	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
D.	NULL
Campbell	NULL
,	NULL
and	NULL
I.	NULL
G.	NULL
Young	NULL
.	NULL

1993	NULL
.	NULL

Sex	NULL
hormones	NULL
and	NULL
dexa-methasone	NULL
modulate	NULL
interleukin-5	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

44:203-210	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
L.	NULL
Hahn	NULL
,	NULL
and	NULL
A.	NULL
Giovane	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

211:7-18	NULL
.	NULL

Wen	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
1995	NULL
.	NULL

Maximal	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
Stat1	NULL
and	NULL
Stat3	NULL
requires	NULL
both	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphor-ylation	NULL
.	NULL

Cell	NULL
82:241-250	NULL
.	NULL

Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
A.	NULL
G.	NULL
Harpur	NULL
,	NULL
R.	NULL
R.	NULL
Kurban	NULL
,	NULL
S.	NULL
J.	NULL
Ralph	NULL
,	NULL
G.	NULL
Zurcher	NULL
,	NULL
and	NULL
A.	NULL
Ziemiecki	NULL
.	NULL

1991	NULL
.	NULL

Two	NULL
novel	NULL
protein-tyrosine	NULL
kinases	NULL
,	NULL
each	NULL
with	NULL
a	NULL
second	NULL
phosphotransferase-related	NULL
catalytic	NULL
domain	NULL
,	NULL
define	NULL
a	NULL
new	NULL
class	NULL
of	NULL
protein	NULL
kinase	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2057-2065	NULL
.	NULL

6840	NULL
80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

LECINE	NULL
ET	NULL
AL	NULL
.	NULL

Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
Miura	NULL
,	NULL
K.	NULL
S.	NULL
Lai	NULL
,	NULL
C.	NULL
Cwik	NULL
,	NULL
E.	NULL
T.	NULL
Lin	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thile	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
JAK-3	NULL
janus	NULL
kinase	NULL
in	NULL
signalling	NULL
by	NULL
inter-leukins	NULL
2	NULL
and	NULL
4	NULL
in	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
370:153-157	NULL
.	NULL

Wurster	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
G.	NULL
Siu	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hedrick	NULL
.	NULL

1994	NULL
.	NULL

Elf-1	NULL
binds	NULL
to	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
a	NULL
second	NULL
CD4	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6452-6463	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
W.	NULL
E.	NULL
Thierfelder	NULL
,	NULL
B.	NULL
L.	NULL
Kreider	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
83	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Ihle	NULL
.	NULL

1994	NULL
.	NULL

Stat4	NULL
,	NULL
a	NULL
novel	NULL
gamma	NULL
interferon	NULL
activation	NULL
site-binding	NULL
protein	NULL
expressed	NULL
in	NULL
carly	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4342-4349	NULL
.	NULL

Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Wen	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Stat3	NULL
and	NULL
Statd	NULL
:	NULL
members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
]	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:4806-4810	NULL
.	NULL

